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Abstract 
 
 
Bioimpedance approaches are given much attention by many researchers from different fields. 
Scientists from biological, industrial and medical backgrounds performed much research and 
development combining state-of art technology, electronics, medical research and 
bioimpedance approaches. 
 
 Bioimpedance techniques have a lot of advantages such that: Low cost of measurements and 
instrumentation, easiness to be used, the ability to be applied non invasively, enable online 
monitoring and finally low hazard. 
 
While impedance is a characteristic property of any material, bioimpedance measurements can 
give valuable information about the tissue under measurement, hence characterizing the tissue 
or monitoring a physiological event. In some cases bioimpedance techniques can be an 
important alternative for an invasive measurement. Bioimpedance measurement is done using 
an external current source. This measurement can be used for characterizing the tissue or for 
the purpose of obtaining other information such as differentiate between normal and cancerous 
tissues. 
 
The research part in this work includes two phases; the first phase includes the pilot 
measurements using wet lab and dry lab. In dry lab the simulated biological tissue based on 
electronic circuit with known impedance value is used instead of real human tissue in order to 
test the bioimpedance analyzer and to verify the instrumentation accuracy while 10 blood 
samples are used in this pilot measurements in the wet lab. The main objectives of this pilot 
measurements is to verify the experimental procedure that will be used in the second phase 
which will include larger number of human blood samples. 
 
From the two phases the impedance measurements are obtained. The impedance values are 
translated to give valuable information about the blood tissue under measurement including 
 v 
 
blood Haematocrit HCT, blood intracellular water content ICW, and extracellular water 
content ECW.  
 
Special program is built  using LABVIEW for continuous measurements of bioimpedance, 33 
fresh human blood samples are used, for each blood sample the multi-frequency impedance 
measurements are taken at six frequencies. For data analysis, a special program is built using 
MATLAB in which the complex  impedance as function of frequency, impedance module  and 
phase angles are all fitted into the Cole-Cole model. Cole-Cole parameters are evaluated 
including characteristic frequency fc, and the characteristic parameter of the distribution of the 
relaxation frequencies α.  
 
The impedance values at zero frequency R0 and infinite frequency R are then extrapolated  
from the Cole-Cole model and used in the estimators to determine the blood  Extracellular 
volume (ECW) ,Intracellular volume (ICW) and  Haematocrit (HCT). 
 
Different estimators are used: 
 
1) Xitron first generation Estimator. 
2) Xitron second generation Estimator. 
3) Surkhi Estimator.  
 
For each of the 33 blood samples the accuracy of those estimators in evaluating blood water 
content and blood Haematocrit are evaluated and compared to results of blood Haematocrit 
sample measured using clinical blood analyzer . 
 
 
 
 
 
 
 
 
 
 
 vi 
 
 
 
 
 
Table of Contents 
 
LIST OF TABLES ............................................................................................................................ IX 
LIST OF FIGURES ............................................................................................................................ X 
LIST OF APPENDICES ................................................................................................................. XII 
LIST OF ACRONYMS ............................................................................................................ XIII 
CHAPTER ONE: INTRODUCTION ..................................................................................... 1 
1.1 Research Objectives ............................................................................................................................. 1 
1.2 Research Problem and Possible Contribution ............................................................................. 2 
CHAPTER TWO: STATE OF THE ART ............................................................................. 4 
2.1 Historical Review ................................................................................................................................... 4 
CHAPTER THREE: THEORY: PRINCIPLE OF BIOIMPEDANCE 
MEASUREMENTS ......................................................................................................................... 9 
3.1 Theoretical Background ...................................................................................................................... 9 
3.2 Bioimpedance measurements ........................................................................................................ 12 
3.3 Hanai Mixture Theory ........................................................................................................................ 18 
CHAPTER FOUR: EXPERIMENTAL METHODS AND INSTRUMENTS ..... 19 
4.1 Instruments and Tools ...................................................................................................................... 19 
4.2 Basic Estimators of Blood volumes from bioimpedance data............................................. 20 
4.2.1 Data Analysis Approach (Used Estimators) ........................................................................... 20 
4.2.2 Data Analysis Approach (Developed Estimator: Surkhi ICW Estimator) ................... 25 
CHAPTER FIVE: PHASE ONE MEASUREMENTS AND RESULTS (PILOT 
MEASUREMENTS) .................................................................................................................... 26 
5.1 Dry measurements: Impedance measurements using Microtest impedance analyzer 
and tissue simulator................................................................................................................................... 27 
5.1.1 Microtest impedance analyzer .................................................................................................... 27 
5.1.2 Biological tissue simulator ........................................................................................................... 28 
5.2 Results from Dry Measurements\Phase One ............................................................................ 31 
 vii 
 
5.3 Wet measurements: Impedance measurements using Local Impedance analyzer 
and blood tissue samples ......................................................................................................................... 37 
5.3.1 Blood Sample Preparation ........................................................................................................... 37 
5.3.2 Blood Chamber and Impedance Probe.................................................................................... 38 
5.3.3 Local tissue Impedance Spectroscopy System .................................................................... 40 
5.3.4 Measurement software .................................................................................................................. 42 
5.4 Results from Wet Measurements\Phase One ........................................................................... 43 
5.4.1. Measured Data: .............................................................................................................................. 45 
5.4.2 Cole-Cole model fitting ................................................................................................................. 46 
5.5 Conclusions from Phase One .......................................................................................................... 49 
CHAPTER SIX: PHASE TWO MEASUREMENTS AND RESULTS 
(RESEARCH MEASUREMENTS) ...................................................................................... 52 
6.1 Blood Samples ...................................................................................................................................... 52 
6.2 Phase Two Objectives ........................................................................................................................ 53 
6.3 Phase Two Experimental Procedure ............................................................................................. 56 
6.4 Phase Two: Results ............................................................................................................................ 61 
6.4.1 Haematocrit Estimators ................................................................................................................ 61 
6.4.1.1. Xitron First Generation:........................................................................................................... 61 
6.4.1.2. Xitron Second Generation: ..................................................................................................... 63 
6.4.1.3. Developed Surkhi Estimator Results: ................................................................................ 65 
6.4.1.4. Comparison between Used and Developed Estimators: ............................................. 67 
6.4.2. ECW, ICW Volumes Estimation: ............................................................................................... 69 
6.4.2.1. Theoretical Volumes:................................................................................................................ 69 
6.4.2.2. First Generation Volumes Estimation: ............................................................................... 71 
6.4.2.3. Second Generation Volumes Estimation: ......................................................................... 72 
6.4.2.4. Developed Surkhi Estimator Volumes Estimation: ....................................................... 73 
6.4.2.5. Comparison between Used and Developed Volumes Estimators: ........................... 74 
6.4.3. Cole-Cole Parameters .................................................................................................................. 75 
CHAPTER SEVEN: DISCUSSION OF RESULTS .................................................... 76 
7.1 HCT Error (Absolute and Relative Error) .................................................................................... 76 
7.1.1. Difference between HCT Hospital & University: ................................................................. 76 
7.1.2. Accuracies of Estimators- HCT Error analysis  (Absolute & Relative Error): .......... 78 
7.1.2.1. HCT absolute & relative error related to Hospital HCT: .............................................. 79 
7.1.2.2. HCT absolute & relative error related to University HCT: .......................................... 79 
7.1.2.3. HCT absolute & relative error related to the mean of Hospital and University 
HCT: ................................................................................................................................................................. 80 
7.2 Volumes Error (Absolute & Relative Error) ............................................................................... 80 
7.2.1. Low Frequency Extracellular Volume (Absolute & Relative Error): ............................ 80 
7.2.2. Low Frequency Intracellular Volume (Absolute & Relative Error): ............................. 80 
7.2.3. High Frequency Extracellular Volume Absolute & Relative Error Related to Xitron 
First Generation: ......................................................................................................................................... 81 
7.2.4. High Frequency Intracellular Volume Absolute & Relative Error Related to Xitron 
First Generation: ......................................................................................................................................... 81 
7.2.5. High Frequency Extracellular Volume Absolute & Relative Error Related to Xitron 
Second Generation: ................................................................................................................................... 81 
7.2.6. High Frequency Intracellular Volume Absolute & Relative Error Related to Xitron 
Second Generation: ................................................................................................................................... 82 
 viii 
 
7.2.7. High Frequency Extracellular Volume Absolute & Relative Error Related to Surkhi 
Estimator: ...................................................................................................................................................... 82 
7.2.8. High Frequency Intracellular Volume Absolute & Relative Error Related to Surkhi 
Estimator: ...................................................................................................................................................... 82 
7.2.9. A Summary of Volumes Absolute and Relative Errors: ................................................... 83 
CHAPTER EIGHT: CONCLUSIONS, LIMITATIONS AND FUTURE 
WORK ............................................................................................................................................... 85 
8.1 Conclusions ............................................................................................................................................ 85 
8.2 Limitations ............................................................................................................................................. 89 
8.3 However its worth to mention?...................................................................................................... 89 
8.4 Recommendation for Future Work................................................................................................ 90 
REFERENCES ............................................................................................................................... 91 
APPENDICES ............................................................................................................................... 94 
صخلملا ............................................................................................................................................... 114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
 
 
 
List of Tables 
 
TABLE 5.1: IMPEDANCE ANALYZER SPECIFICATIONS . ........................................................................................... 27 
TABLE 5.2: THEORETICAL VALUES FOR IMPEDANCE MODULE AND PHASE ANGLE FROM THE TISSUE SIMULATOR
 ...................................................................................................................................................................... 30 
TABLE 5.3: MEASURED IMPEDANCE MODULE AT 6 FREQUENCIES . ...................................................................... 32 
TABLE 5.4: MEASURED PHASE MODULE AT 6 FREQUENCIES . ............................................................................... 32 
TABLE 5.5: RELATIVE ERROR OF THE MEASURED IMPEDANCE MODULE AT 6 FREQUENCIES . ............................. 33 
TABLE 5.6: RELATIVE ERROR OF THE MEASURED PHASE ANGLE AT 6 FREQUENCIES . .......................................... 33 
TABLE 5.7: THEORETICAL & MEASURED HCT . ....................................................................................................... 43 
TABLE 5.8: COLE-COLE PARAMETERS . .......................................................................................................... 48 
TABLE 5.9: HIGH FREQUENCY ICW ESTIMATOR. .................................................................................................... 48 
TABLE 5.10: HIGH FREQUENCY ICW ESTIMATOR. .................................................................................................. 49 
TABLE 6.1: FIRST GENERATION RESULTS . .............................................................................................................. 62 
TABLE 6.2: SECOND GENERATION RESULTS . ......................................................................................................... 64 
TABLE 6.3: DEVELOPED SURKHI ESTIMATOR RESULTS . ......................................................................................... 66 
TABLE 6.4: THEORETICAL VOLUMES . .................................................................................................................... 70 
TABLE 6.5: XITRON FIRST GENERATION VOLUMES ESTIMATION . ......................................................................... 71 
TABLE 6.6: XITRON SECOND GENERATION VOLUMES ESTIMATION . .................................................................... 72 
TABLE 6.7: DEVELOPED SURKHI ESTIMATOR VOLUMES ESTIMATION . ................................................................. 73 
TABLE 6.8: COLE-COLE PARAMETERS . ................................................................................................................... 75 
TABLE 7.1: DIFFERENCE BETWEEN HCT HOSPITAL & UNIVERSITY . ....................................................................... 77 
TABLE 7.2: HCT ABSOLUTE & RELATIVE ERROR RELATED TO HOSPITAL HCT . ....................................................... 79 
TABLE 7.3: HCT ABSOLUTE & RELATIVE ERROR RELATED TO UNIVERSITY HCT . ................................................... 79 
TABLE 7.4: HCT ABSOLUTE & RELATIVE ERROR RELATED TO MEAN OF HOSPITAL & UNIVERSITY HCT . ............... 80 
TABLE 7.5: LOW FREQUENCY EXTRACELLULAR VOLUME ABSOLUTE AND RELATIVE ERROR . ............................... 80 
TABLE 7.6: LOW FREQUENCY INTRACELLULAR VOLUME ABSOLUTE AND RELATIVE ERROR . ............................... 81 
TABLE 7.7: HIGH FREQUENCY EXTRACELLULAR VOLUME ABSOLUTE & RELATIVE ERROR RELATED TO XITRON 
FIRST GENERATION . ..................................................................................................................................... 81 
TABLE 7.8: HIGH FREQUENCY INTRACELLULAR VOLUME ABSOLUTE & RELATIVE ERROR RELATED TO XITRON 
FIRST GENERATION . ..................................................................................................................................... 81 
TABLE 7.9: HIGH FREQUENCY EXTRACELLULAR VOLUME ABSOLUTE & RELATIVE ERROR RELATED TO XITRON 
SECOND GENERATION . ................................................................................................................................ 82 
TABLE 7.10: HIGH FREQUENCY INTRACELLULAR VOLUME ABSOLUTE & RELATIVE ERROR RELATED TO XITRON 
SECOND GENERATION . ................................................................................................................................ 82 
TABLE 7.11: HIGH FREQUENCY EXTRACELLULAR VOLUME ABSOLUTE & RELATIVE ERROR RELATED TO SURKHI 
ESTIMATOR . ................................................................................................................................................. 82 
TABLE 7.12: HIGH FREQUENCY INTRACELLULAR VOLUME ABSOLUTE & RELATIVE ERROR RELATED TO SURKHI 
ESTIMATOR . ................................................................................................................................................. 83 
TABLE 7.13-A: VOLUMES ABSOLUTE & RELATIVE ERRORS RELATED TO XITRON FIRST GENERATION . ................ 83 
TABLE 7.13-B: VOLUMES ABSOLUTE & RELATIVE ERRORS RELATED TO XITRON SECOND GENERATION . ............ 83 
TABLE 7.13-C: VOLUMES ABSOLUTE & RELATIVE ERRORS RELATED TO SURKHI ESTIMATOR . ............................. 84 
 
 x 
 
 
 
 List of Figures 
 
FIGURE 3.1: BIOLOGICAL CELL MICROSTRUCTURE . ..................................................................... 10 
FIGURE 3.2: ELECTRICAL MODEL OF CELL MEMBRANE MICROSTRUCTURE . ....................... 11 
FIGURE 3.3: EQUIVALENT CIRCUIT MODEL FOR BIOLOGICAL TISSUE . ................................ 11 
FIGURE 3.4: PRINCIPLE OF THE ELECTRICAL BIOIMPEDANCE . ................................................ 12 
FIGURE 3.5: LOW FREQUENCY EQUIVALENT CIRCUIT. ................................................................. 13 
FIGURE 3.6: HIGH FREQUENCY EQUIVALENT CIRCUIT . ............................................................... 14 
FIGURE 3.7: DEBYE (LEFT) & COLE-COLE (RIGHT) MODELS . .................................................... 16 
FIGURE 3.8: CURRENT PATH IN LOW AND HIGH FREQUENCY . ................................................. 17 
FIGURE 3.9: NON-CONDUCTING SPHERES (CELLS) IN CONDUCTING MEDIA (PLASMA) .
 ...................................................................................................................................................................... 18 
FIGURE 4.1: RESISTANCE CALCULATION . ......................................................................................... 21 
FIGURE 4.2: EQUATION (4.6) RESULTS WITH LINEAR APPROXIMATION . ............................ 23 
FIGURE 5.1: MULTI FREQUENCY IMPEDANCE ANALYZER ............................................................ 28 
FIGURE 5.2: BIOLOGICAL TISSUE SIMULATOR ............................................................................... 29 
FIGURE 5.3: BIOLOGICAL TISSUE SIMULATOR SCHEMATIC CIRCUIT . .................................. 30 
FIGURE 5.4: COMPLETE CONNECTION BETWEEN MULTI FREQUENCY IMPEDANCE 
ANALYZER TISSUE SIMULATOR . ..................................................................................................... 31 
FIGURE 5.5: ONE SAMPLE OF THE MEASURED IMPEDANCE IN THE COMPLEX PLANE . ... 34 
FIGURE 5.6: IMPEDANCE MODULE AS FUNCTION OF FREQUENCY . ........................................ 35 
FIGURE 5.7: PHASE ANGLE AS FUNCTION OF FREQUENCY ........................................................ 36 
FIGURE 5.8: THE BLOOD CHAMBER AND IMPEDANCE PROBE . ................................................. 38 
FIGURE 5.9: THE BLOOD CHAMBER AND IMPEDANCE PROBE . ................................................. 38 
FIGURE 5.10: THE EXPERIMENTAL SETUP . ....................................................................................... 41 
FIGURE 5.11: DATA ACQUIRING PROGRAM . .................................................................................... 42 
FIGURE 5.12: THEORETICAL AND MEASURED HCT FOR THE 10 BLOOD SAMPLES . ......... 44 
FIGURE 5.13: IMPEDANCE MODULE AND PHASE ANGLE AT 6 FREQUENCIES FOR SAMPLE 
02 . .............................................................................................................................................................. 45 
FIGURE 5.14: IMPEDANCE PLOTTED IN THE COMPLEX PLANE FOR SAMPLE 02. (A) ALL 
MEASURED DATA (B) DATA AVERAGE . ........................................................................................ 46 
FIGURE 5.15: IMPEDANCE PLOTTED IN THE COMPLEX PLANE FOR SAMPLE02(HCT=0.4) 
AND SAMPLE04(HCT=0.3) . ............................................................................................................... 47 
FIGURE 5.16: HAEMATOCRIT VALUE BY FIRST AND SECOND GENERATION FOR 
SAMPLE02 . .............................................................................................................................................. 50 
FIGURE 6.1: BLOOD SAMPLES ON THE SHAKER . ............................................................................ 57 
FIGURE 6.2: A BLOOD SAMPLE IN THE CHAMBER . ........................................................................ 57 
FIGURE 6.3: CONNECTING CHAMBER WITH FREQUENCY ANALYZER ELECTRODES ......... 58 
FIGURE 6.4: HAEMATOLOGY ANALYZER . ........................................................................................... 59 
FIGURE 6.5: CAPILLARY TUBES . ............................................................................................................ 59 
FIGURE 6.6: HAEMATOCRIT VALUE BY FIRST AND SECOND XITRON GENERATION AND 
SURKHI ESTIMATOR FOR SAMPLE15. ............................................................................................ 67 
FIGURE 6.7: COMPARISON BETWEEN USED AND DEVELOPED ESTIMATOR IN 
DETERMINING HCT VALUE FOR SAMPLE15. ................................................................................ 68 
 xi 
 
FIGURE 6.8: COMPARISON BETWEEN USED AND DEVELOPED ESTIMATOR IN 
DETERMINING VOLUMES FOR SAMPLE15. ................................................................................... 74 
FIGURE 7.1: DIFFERENCE BETWEEN HCT HOSPITAL AND HCT UNIVERSITY. ...................... 78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xii 
 
 
 
List of Appendices 
 
APPENDIX A: THE OUTGOING BOOKS .......................................................................................................... 95 
APPENDIX B: MATLAB CODES ........................................................................................................................ 96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiii 
 
 
List of Acronyms 
 
 
Abs Absolute 
BCM  Body Cell Mass  
BI Bio-Impedance 
BIA Bio-Impedance Analysis 
BIS Bio-Impedance Spectroscopy   
CBC Cell Blood Counter 
ECF extra-cellular fluid 
ECW Extra Cellular Water  
Fc Characteristic Frequency 
HCT Haematocrit 
HF High Frequency  
HGH Hebron Governmental Hospital 
ICW Intra Cellular Water 
LF Low Frequency 
RPM Revolution Per Minute 
TBK Total Body potassium(K) 
TBW Total Body Water 
TTW Total Tissue Water  
 
 1 
 
 
 
 
 
 
 
 
 
 
Chapter One: Introduction  
 
 
1.1 Research Objectives  
 
In this thesis human blood tissue is characterized using electrical bioimpedance spectroscopy 
measurements. There are two phases of work including dry and wet lab according to working 
with simulated biological tissues or human blood tissue respectively. 
 
The main objectives of this work are: 
 
1) Perform electrical bioimpedance spectroscopy measurements using wide frequency 
range on human blood tissue. 
2) Evaluate tissue parameters out of the bioimpedance measurements such as : 
 Intracellular water volume  
 Extracellular water volume  
 Blood Haematocrit (HCT) 
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3) Study and compare the most used ICW and ECW estimators available in literature  
4) Study the accuracy of ICW and ECW estimators and try to indicate source of 
inaccuracies. 
5) Develop new ICW and ECW estimators . 
 
 
 
1.2 Research Problem and Possible Contribution 
 
Different estimators are used by bioimpedance systems producing company such as Xitron 
company. Those estimators include Xitron first generation and Xitron second generation 
that differs from each other in estimating tissue intracellular water content.  
 
This thesis is trying to study those estimators and prove if they give accurate estimating for 
tissue intracellular and extracellular water contents or not. The biological tissue that is 
used in this thesis is human blood tissue, so this thesis used the most used estimators in 
literature which are Xitron first and second generations to estimate human blood 
intracellular and extracellular water contents along with Haematocrit. Add to that using the 
developed Surkhi estimator to estimate the mentioned parameters above and try to 
compare, analyze and discuss the results to indicate the most accurate estimator.  
 
The Cole-Cole parameters are also extrapolated and calculated to find the characteristic 
values of human blood tissue. 
 
 From the above research problem and objectives points; the contribution and outcomes 
from this work can be guessed to be as follows: 
 
1) Measure the intracellular and extracellular water contents in the tissue based on low and 
high frequency measurements. Most of common used estimators for ECW water is based 
on low frequency measurements. There are fewer works dealing with ICW at high 
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frequency than with ECW. In most cases ICW is obtained by subtracting ECW from total 
tissue volume.  
 
2) Different ECW and ICW estimators are currently used, many authors have reported 
inaccuracies in those estimators and errors in their results. In this work different 
estimators will be compared and analyzed.  
 
3) Develop blood Haematocrit HCT estimator based on high frequency impedance 
measurements. Currently the used method to estimate blood HCT is using low frequency 
measurements to evaluate the blood ECW. In this work the blood HCT is evaluated using 
high frequency measurements to evaluate blood cell content.  
 
4) Different blood samples are used with different medical conditions (different HCT 
values, different health conditions) and investigated. blood condition Indicators based on 
bioimpedance measurements are developed.  
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Chapter Two: State of the Art 
 
 
2.1 Historical Review  
 
Bioimpedance research has attracted many researchers from different fields of specialization 
due to the advantages of this approach. Dielectric properties are characteristic property of any 
material. Bioimpedance measurements can give valuable information about the tissue under 
measurement, hence characterize the  tissue or monitor a physiological event.  In some cases 
bioimpedance measurements become a noninvasive solution. Nowadays bioimpedance 
techniques are commercially available and it is the basic principle of several medical 
instrumentation used for different  purposes such as monitoring, imaging and diagnostic 
systems.  
 
One of the first researchers that had worked in this field is G.N. Stewart in the year 1894 when 
he studied the blood circulation between organs depending on the blood electrical 
conductivity. After that he detected the growth of the bacteria based on the electrical 
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conductivity changes of the culture media[1]. Hober in the year 1910 measured the electrical 
impedance of red blood cell suspensions and concluded that the cells are surrounded by a 
poorly conducting membrane[2].  
 
The electrical properties of the pleuropneumonia-like organism over the frequency range from 
0.5 to 250 MHz is determined by P. Schwan et al. in 1962 [3], in his model and after analyzing 
the obtained data, the cells displayed frequency dependent capacitance and conductivity 
values.  
 
The electrical properties of tissues, macromolecular solutions and cell membranes at 
frequencies from the extra low frequency to microwave range is summarized by P. Schwan in 
1980  [4]. In that work, the electrical properties of tissues which are the conductivity, 
resistivity and the dielectric permittivity relative to free space are reviewed covering the total 
frequency spectrum up to microwave frequencies.  
 
In 1987, A review of the dielectric properties of various mammalian tissues and biological 
fluids for the frequency range from 1 Hz to 10 GHz is given by Pething, the properties that are 
considered are the permittivity and the electrical conductivity[5], in his paper he showed that 
the dielectric properties of all tissues tend to follow the same dependence on frequency and in 
the range of frequencies from 100KHz to 100MHz there are large changes in dielectric 
properties associated with the resistive nature of cell membranes, also he showed that there are 
dielectric differences between normal and cancerous tissue because the cancerous cells have a 
higher water content and sodium concentration than the normal one, also the electrochemical 
properties of their cell membranes are different. 
 
Measuring the extracellular water (ECW), Total Body Water (TBW) and the intracellular 
water (ICW) by using the bioimpedance spectroscopy is first reported in 1992[6]. In vitro 
electrical impedance spectroscopy is performed on tissue samples excised from sheep in the 
year 1995 by Rigaud et. al.. The measured data have been processed to reduce dispersion in 
measurements and to provide a criteria that is useful for tissue comparison, two electrical 
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model are proposed for tissue which are the one-circle impedance locus and the two-circle 
impedance locus[7].  
In the year 1996, a parametric model is developed by S. Gabriel et. al. to describe the variation 
of dielectric properties of tissues as a function of frequency, the experimental spectrum from 
10 Hz to 100 GHz is modeled with four dispersion regions[8].  
 
Maasrani et.al. in 1997 tested a technique for continuous measurements of Haematocrit and 
plasma volume in the arterial line of dialyzed patients in vitro and in vivo, that technique uses 
impedance measurements at 5 KHz and require a single Haematocrit measurement[9], his 
study is relied on two assumptions, the first is that the plasma resistivity does not change 
during dialysis and the second is that the blood resistivity obeys Hanai‟s model. The 
Haematocrit measured in vivo by that method is in good agreement with the direct 
measurements from blood samples, then he used the Haematocrit variation to monitor the 
changes in the plasma volume.  
 
The body cell mass is predicted in 1997 by Delorenzo et.al. using bioimpedance based on 
theoretical methods, a technological review is done, in this method the body cell mass (BCM) 
defined as intracellular water (ICW) is estimated in 73 healthy men and woman by using the 
total body potassium (TBK) and by bioimpedance spectroscopy (BIS), in other 14 subjects 
extracellular water (ECW) and total body water (TBW) are measured by using bromide 
dilution and deuterium oxide dilution, the Cole-Cole model and Hanai Mixture theory are used 
to obtain the unknown volumes and parameters[10].  
 
In the year 1997, a method is presented in order to monitor the relative variation of 
extracellular and intracellular fluid volumes using the Cole-Cole extrapolation technique and 
using the multifrequency impedancemeter, this method is presented by Jaffrin et.al.[11]. 
Jaffrin found that the extrapolation is necessary to obtain reliable data for the resistance of the 
intracellular fluid, the extracellular and intracellular resistances can be approached using 
frequencies of 5KHz and 1MHz, and he found that the use of 100KHz leads to an 
unacceptable errors. 
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The clinical achievements in which the applications of bioimpedance techniques are 
extensively extended and managed to find their place in the routine clinical and industrial 
world is reviewed by O. Al-Surkhi [12]. In his paper Al-Surkhi tried to review some of the 
achievements technological in clinical practice with some examples from the medical industry 
products. First he reviewed the techniques that are used in the assessment of body composition 
with its two branches which are the Bioimpedance Analysis (BIA) in which it uses a single 
frequency for measurement and the Bioimpedance Spectroscopy (BIS) in which a range of 
frequencies are used. Monitoring the body fluid during haemodialysis and how Bioimpedance 
techniques can provide noninvasive measurements of the Total Body Water (TBW), the 
distribution of intra (ICW) and extracellular (ECW) fluids and how they changes during 
haemodialysis are discussed. How the blood Haematocrit can be monitored by using 
Bioimpedance are also mentioned, then he described the method used in cardiology depending 
upon Bioimpedance. After that he mentioned the image that is taken by using Bioimpedance 
approach using a set of electrodes to form an array around the volume conductor of interest to 
obtain the image after processing. Finally he described how abnormal tissues can be 
characterized and monitored by using Bioimpedance. In addition the technique of electrical 
impedance spectroscopy for in-vivo and in situ characterization of different organ tissues in 
normal state and with the progress of tissue ischemia level is reported by O. Al-Surkhi [13]. In 
this paper he took in-vivo measurements of different tissues from pigs using electrical 
impedance spectroscopy analyzer with frequency range between 100KHz to 1MHz with a 4-
electrodes system, and in those measurements different degrees of ischemia are obtained in the 
tissue by the occlusion of the arterial blood supply, he adjusted the experimental data to the 
Cole-Cole model and the Cole parameters are eventually calculated.  
 
In 2010 Richelle Leanne Gaw thesis entitled “The Effect of Red Blood Cell Orientation on the 
Electrical Impedance of Pulsatile Blood with Implications for Impedance Cardiography” to 
obtain the degree of philosophy doctoral studied the impedance cardiography as an application 
of bioimpedance analysis primarily used in a research setting to determine cardiac output. The 
cardiac output is calculated from the measured impedance using the parallel conductor theory 
and a constant value for the resistivity of blood. The resistivity of blood has been shown to be 
velocity dependent due to changes in the orientation of red blood cells induced by changing 
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shear forces during flow. The overall goal of his thesis is to study the effect that flow 
deviations have on the electrical impedance of blood [15].  
 
S. Abdalla et. al. in the year 2010 studied the effects of the blood microstructure on the 
electrical conduction from two different but correlated properties: Electrical and Mechanical 
(Viscosity), and derive useful parameters for the evaluation of electrical conduction as a 
function of the blood viscosity. In their work, they have shown that bioimpedance 
measurements could provide an important method for the noninvasive investigation of blood 
internal structure and properties for monitoring physiological change i.e., “static” or 
“dynamic” human organism properties [16]. 
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Chapter Three: Theory: Principle of Bioimpedance Measurements  
 
 
3.1 Theoretical Background  
 
The main principle of Bioimpedance measurements is quite simple and depends on how the 
biological tissues respond to an applied external electrical field.  
 
Biological tissues consists of cells which are the main building blocks of any tissues. 
Biological cell microstructure can be modeled into three main components which are:  
 
1) Extracellular water (ECW). 
2) Intracellular water (ICW). 
3) Cell membrane that separates between ECW and ICW. 
Figure 3.1 represents a typical biological cell. As shown in figure 3.1, each cell in the body is 
surrounded by a cell membrane with the known  lipid bilayer structure. The cells contain intra-
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cellular fluid, abbreviated ICF (also called ICW for intra-cellular water). The cells are 
surrounded by extra-cellular fluid, ECF (also called ECW).  
 
 
Figure 3.1: Biological Cell Microstructure . 
 
The cell membrane is known to have a lipid Bilayer structure. Lipids also known to have 
dielectric properties thus the cell membrane microstructure is a non conductive structure 
acting as an electrical capacitor [1] [10]. Therefore the measured bioimpedance is a function 
of frequency of the ejected electrical current.  
 
At low frequency LF (approaching to zero Hz), the cell membrane will act as an open circuit 
capacitor and blocking the electrical current to penetrate the ICW space and the current will 
pass though only the ECW space. In this case the measured impedance is pure resistive and 
represents the impedance of the ECW volume. 
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 At high frequency HF(approaching to infinite Hz) the cell membrane will act as a short circuit 
capacitor  allowing  the electrical current to penetrate both the ICW and ECW spaces and the 
measured impedance is also pure resistive and represents the impedance of the ICW and ECW 
volumes (TBW).   
 
The biological tissue can be modeled with an electrical model. Both the extracellular and 
intracellular water content are modeled with resistances while the cell membrane is 
implemented by a capacitor as shown in figure (3.2).  
 
 
Figure 3.2: Electrical Model of Cell Membrane Microstructure . 
 
Thus the equivalent electrical circuit model of biological tissue can be represented in the 
following figure [10]: 
 
 
 
 
 
 
 
 
Figure 3.3: Equivalent Circuit model for biological tissue . 
 
Where: 
𝑅𝐸𝐶𝑊 : Extracellular water content resistance. 
𝑅𝐼𝐶𝑊 :  Intracellular water content resistance. 
𝐶𝑚 : Cell membrane capacitance.  
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3.2 Bioimpedance measurements  
 
Bioimpedance measurements are performed by injecting an electrical current with certain 
frequency in to the biological cell which has a geometric properties such as length and 
volume. It has a dielectric properties such as conductivity and permittivity. If electrical current 
injection occurs, an induced voltage will be obtained and voltage can be measured. As the 
injected current is known and the induced voltage is measured, the impedance (Z) can be 
calculated and it is called bioimpedance as the deal here with biological cells. Bioimpedance 
will be a function of frequency, dielectric properties and geometry, then the expression of 
biological impedance will be as follows : 
Z  Ω =  
V (volt)
I (amp)
                 (Ohm′s Law) 
 
Eq(3.1) 
In order to understand the principle of the electrical bioimpedance, see figure 3.4. 
Figure 3.4: Principle of the Electrical Bioimpedance . 
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From bioimpedance measurement a physiological information can be gotten about cells and 
tissues within the human body such as hydration, cell type and orientation, the state of the cell 
membranes and others.  
 
As mentioned previously, if the current is injected with certain frequency through biological 
cell, an induced voltage will be obtained and bioimpedance can be calculated from that two 
parameters. Suppose that the frequency of the injected current is low; then at low frequencies 
it is assumed that the current flow is limited to the Extracellular Water (ECW) because the cell 
membranes act as capacitors and as known that at low frequencies the capacitor will be an 
open circuit so the current will not penetrate through the intracellular water (ICW) and go 
around the cell through ECW as the current flow through extracellular fluid only and the 
measured impedance is Z0 = ZECW (see figure 3.5). 
 
 
Figure 3.5: Low Frequency Equivalent Circuit. 
 
Hence at low frequencies bioimpedance is regarded as a measure of the ECW. The measured 
impedance at low frequencies is a Pure Resistive (Real Ro). 
 
Z Low  Frequency :      R0 =  RECW   
 
 
Eq(3.2) 
 
At higher frequencies the electric current flows through the Intracellular water  (ICW) as well 
as the ECW because the cell membranes act as capacitors and at high frequencies the capacitor 
will be a closed circuit so the  impedance index  is a measure of the volume of the Total Tissue 
Water  (TTW). 
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Figure 3.6: High Frequency Equivalent Circuit . 
 
At high frequencies the body is modeled as two resistors in parallel, one representing the 
resistance of the ECW, the other is the ICW. The resultant impedance is that obtained from the 
two resistors in parallel and it is a Pure Resistive (Real R∞) as the current flow through the 
total tissue fluid and the measured Z∞ =  ZICW // ZECW   
 
Z High  Frequency :       R∞ =  
 RECW RICW  
 RECW + RICW  
 
 
Eq(3.3) 
 
From eq(3.2) and eq(3.3) one can write : 
R∞
Ro
 =
RICW
RICW + RECW
       
 
Eq(3.4) 
 
At low frequencies, the measured impedance will be only the ECW resistance whereas at high 
frequencies, the measured impedance will be the resultant impedance from ECW and ICW as 
they are in parallel. RECW is known from the first case so RICW can be computed. 
 
At Frequencies between low and high frequencies, Cell Membrane (Capacitor) will play an 
important part. Hence bio-impedance will consist of two parts which are Pure & Complex. 
 
Z Frequencies  Between =  R + jXc  Eq(3.5) 
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Experimentally it is found that the change of impedance as a function of the measurement 
frequency can be described with a mathematical equation which is the mathematical solution 
for the electrical model of the biological model that takes the following form according to 
Cole-Cole model: 
 
Z*=R¥+
R0-R¥
1+ j
f
f0
æ
è
ç
ö
ø
÷
1-a
                                                      [11] [14] [17]
 
 Eq(3.6) 
 
Z Frequencies  Between =  R + jXc  
 
Eq(3.7) 
 
Where: Z
*
: complex impedance 
  R0: limiting impedance at low frequencies 
  R: limiting impedance at high frequencies 
  α: shape factor 
fc: characteristic frequency, at which the imaginary part displays the minimum 
value 
 
Equation(3.6) is referred to Cole Equation or Cole-Cole Equation [11] [14] [17]. It is worth 
noting that the limiting values at low and high frequencies, R0 and R, are not measurable in 
practice, because of other effects showing up when the measured frequency decreases or 
increases far from f0.  
 
This idea will be clear when drawing the measured impedances in the complex plane (real by 
imaginary) (see figure 3.7) [1] [14] [18]. 
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Figure 3.7: Debye (Left) & Cole-Cole (Right) Models . 
 
The measured data isn‟t fitting to Debye model. There is a depression when drawing the 
measurements in the complex plane. Debye model is enhanced by Cole-Cole model by adding 
the shape factor (α) which represents the depression value or the arc center. The ideal 
capacitor element that is used in the earlier models is replaced by “Constant Phase Element” 
(CPE) in order to fit the modeled impedance with the actual biological measurements. 
 
CPE cannot be physically represented by ordinary electrical component, but it is described as 
capacitance that is frequency dependent and at α = 0, CPE will act like ideal capacitor.  
 
The representation of the Cole complex impedance in the Wessel diagram (real Vs imaginary 
part of Z) as shown in figure 3.7 does not show a semicircle centered in the real axis (Debye 
Model), instead the center of the arc will be depressed below the real axis depending on the 
value of 𝛼. α in Debye model is set to be zero but it has a value in Cole-Cole model depending 
upon the depression. 
 
The values of R0 and R can be extrapolated by fitting the measurements to Cole-Cole model. 
R0 and R values are the intersection of the semicircle with the x-axis (real (Z)) where R0 at 
the right and R at the left with the direction of increasing the frequency as shown in figure 
3.7. 
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As a result Bio-Impedance is a function of frequency as its value depends upon the frequency 
of the injected current, you can see figure 3.8 to understand how bioimpedance is a function of 
frequency. 
 
Figure 3.8: Current Path in Low and High Frequency . 
 
The idea of bioimpedance spectroscopy (BIS) is to measure the impedance of biological tissue 
at a series of frequencies. This is done by sending weak alternating currents through the tissue, 
while measuring both the impedance and the phase difference for each frequency. 
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3.3 Hanai Mixture Theory 
 
Blood tissue is not a homogenous material as it is a suspension of low conductivity (cells) in 
conducting media (plasma) [9] [18]. For zero frequency, the current can‟t enter the cells and 
flow in the extracellular fluid only. The extracellular fluid has itself resistivity ρECF. The 
current can‟t take the direct route through the fluid but must flow around the cells. For this 
reason the resistivity of the tisse takes a higher value than ρECF. 
 
The apparent resistivity problem was solved and analyzed by Hanai in 1968 by the Apparent 
Resistivity Theory or Hanai Mixture Theory [18]. This theory solves the problem of 
calculating the resistivity of a conducting fluid mixed with non conducting spheres [18]. 
 
According to Hanai results if the non conducting spheres take up the part C of the total volume 
of the conducting media (see figure 3.9). 
 
 
Figure 3.9: Non-Conducting Spheres (Cells) in Conducting Media (Plasma) . 
 
Then: 
C =  
Cell Volume
Total Volume
 
 
Eq(3.8) 
The apparent resistivity is given by Hanai Mixture Theory: 
 
ρ =  
ρECF
 1 − C 3 2 
                                                                                     [18] Eq(3.9) 
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Chapter Four: Experimental Methods and Instruments  
 
 
4.1 Instruments and Tools  
 
The instruments that are used are the following: 
 
1. Multi Frequency Impedance Analyzer –Microtest 6379(Material Lab) 
This instrument measures the impedance with angle according to a predetermined frequency. 
In addition to all other electrical parameters and quantities. The instrument has a software to 
work with. The number of frequencies and all other parameters related to the measurements 
can be determined using the software or the instrument screen directly. The graph between the 
selected parameters can be obtained such as the graph that describes the relationship between 
time and impedance or between time and phase angle for measurements at the determined 
frequencies. 
 
2. Local Tissue Impedance Analyzer : multi frequency impedance spectroscopy  
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3. Tissue simulator :  simulators which are models for biological tissues, they act as biological 
tissues. Those simulators will be used in order to check the validity of the measurements. 
 
4. Clinical Haematocrit (HCT) Analyzer 
The Clinical Haematocrit Analyzer will be used for the verification of the obtained results in 
order to verify the measurements validity.  
 
5. Other Clinical Instruments: cell counter , blood centrifuge , microscope , etc,,, 
 
 
4.2 Basic Estimators of Blood volumes from bioimpedance data 
 
The most important issue is how to translate the bioimpedance data into volumes estimation. 
The most used estimators are Xitron first and second generations. This section reviews those 
two estimators with the developed Surkhi Estimator that are used to make data analysis after 
bioimpedance measurements are taken. 
 
4.2.1 Data Analysis Approach (Used Estimators) 
 
Biological tissues are not homogenous; in fact they are considered as a suspension of 
conducting and non conducting materials. The apparent resistivity of suspensions can be 
calculated by Hanai mixture theory as explained in Chapter Three. The reason for looking at 
resistivity is the need to do calculations on the volume of a fluid.  
 
To connect the result of bioimpedance measurements with the amounts of body fluid, you 
must understand what determines the value of the electrical resistance. 
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Figure 4.1: Resistance Calculation . 
 
The equation that describes the relation between resistance, resistivity, length and area is: 
 
R =  ρ.
L
A
 Eq(4.1) 
 
Where: 
R: is the resistance. 
ρ: is the resistivity. 
L: is the Length. 
A: is the cross-sectional Area. 
 
From equation 4.1, the higher the resistivity, the higher the electrical resistance will be. 
 
Equation 4.1 uses the length and the area. If the length is known, the following relation can be 
used: 
𝑉𝑜𝑙𝑢𝑚𝑒 = 𝐴𝑟𝑒𝑎 × 𝐿𝑒𝑛𝑔𝑡ℎ   
𝑉 = 𝐴 × 𝐿 
 
Eq(4.2) 
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Rewrite equation 4.1 as follows: 
 
R =  ρ.
L
A
=  ρ.
L. L
A. L
= ρ.
L2
V
 
 
Eq(4.3) 
 
Equation 4.3 allows the calculation of the fluid volume in which the current flows: 
R = ρ.
L2
V
                   V = ρ.
L2
R
 
 
Eq(4.4) 
 
At low frequency ECW (plasma in case of blood tissue) is considered as the conducting 
material, and ICW which is surrounded by cell membranes is the non conducting material 
(blood cells in case of blood tissue).  
 
Using Hanai Mixture Theory that gives the apparent resistivity equation and equation (4.4), 
the volume of the ECW (VECW) can be calculated by:  
VECW =  
ρECW L
2VTTV
1
2 
R0
 
2
3 
                                                          [6] [18] 
 
Eq(4.5) 
  
Where: 
ρECW : is the resistivity of the ECW 
L:  is the separation distance between the detection electrodes 
VTTV : the total tissue volume i.e the volume of the blood chamber 
R0:  is the extrapolated impedance at zero frequency 
 
Using the volumetric concentration at high frequency, the volume of the ICW compartment 
(VICW) can be calculated by solving : 
 
 1 +
VICW
VECW
 
5 2 
=
R0
R∞
 1 + KP
VICW
VECW
                                                 [6] [18] Eq(4.6) 
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Where  
  
KP =
ρICW
ρECW
                                                                                         [18] 
 
Eq(4.7) 
Where: 
ρECW, ρICW  are the resistivity of the ECW,ICW in (Ohm.cm) respectively which can be found 
in literature, and R is the extrapolated impedance at infinite frequency. Although there is no 
explicit solution to equation(4.2), a linear relationship may be found for values of ICW/ECW 
in the range 0.8 to 1.5 and for different values of KP (3.4 to 3.8). This ranges of values are 
extracted from literature [6]. 
 
The results of equation (4.6) along with the linear approximation are depicted in figure (4.2): 
 
Figure 4.2: Equation (4.6) results with linear approximation . 
 
And the linear relationship obtained (black dotted line in figure 4.1) is the following: 
 
VICW
VECW
= 1.67
R0
R∞
− 1.067 
 
Eq(4.8) 
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This estimator is reported by many authors [6] [10] and is known to be the first generation 
estimator used by Xitron since 1990 which is a leading company in producing bioimpedance 
systems for fluid estimation.  
 
Recently Xitron revealed the second generation of the ICW estimator and it is reported by 
Matthie et al.2005 as [6]: 
VICW = VECW ×   
ρTBW × R0
ρECW × R∞
 
2
3 
− 1                                                    [6] 
Eq(4.9) 
 
Dividing Eq(4.9) by VECW , Eq(4.10) will be obtained: 
 
VICW
VECW
=   
ρTBW × R0
ρECW × R∞
 
2
3 
− 1  
Eq(4.10) 
 
With: 
ρTBW = ρICW −  ρICW − ρECW  ×  
R∞
R0
 
2
3 
 
Eq(4.11) 
   
Dividing equation (4.11) by ρECW , the following equation is obtained: 
 
ρTBW
ρECW
=
ρICW
ρECW
−  
ρICW
ρECW
−
ρECW
ρECW
 ×  
R∞
R0
 
2
3 
 
Eq(4.12) 
 
 
Substitute KP  instead of 
ρICW
ρECW
 as indicated before in Eq(4.7), the following equation is 
obtained:  
 
ρTBW
ρECW
= KP −  KP − 1 ×  
R∞
R0
 
2
3 
 
Eq(4.13) 
 
From the extrapolated values of impedances at low and high frequencies (R0 and R∞) 
respectively which represent the electrical circuit model resistances using Cole-Cole model 
and by using the computed value of VECW , it is possible to calculate the value of VICW  using 
the equations Eq(4.9) and Eq(4.11). 
 
As noticed this section reviewed first and second Xitron generations or estimators.  
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4.2.2 Data Analysis Approach (Developed Estimator: Surkhi ICW Estimator) 
 
 
The developed estimator by Dr. Omar Al-Surkhi from Al-Quds University in which the 
volume of the intracellular volume content is determined. 
 
At HF the capacitive effect of the cell membrane is minimized and both impedances of the 
ECW and ICW becomes in parallel. Using the conductance expressions for parallel model  
Surkhi estimator is developed to describe the relation between the measured impedance and 
the intracellular volume as: 
 
  
1
2
1
0
1 1ICW ICW
ECW ECW
ICW ECW
ECW ICW
V VR
K
V R V
where
K


 
 


   
     
   
 
 Eq(4.14) 
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Chapter Five: Phase One Measurements and Results (Pilot Measurements) 
 
 
In this thesis two phases of measurements are performed. The first phase includes the pilot 
measurements using wet lab and dry lab. In dry lab the simulated biological tissue based on 
electronic circuit with known impedance values is used instead of real human blood tissue in 
order to test the bioimpedance analyzer and to verify the instrumentation accuracy while 10 
blood samples are used in this pilot measurements in the wet lab. The main objectives of this 
pilot measurements is to verify the instrumentation accuracy, to decide if we can use the 
impedance instrument to measure blood tissue impedance, to adjust the experimental 
parameters such as blood chamber parameters and to decide whether to use multi blood 
samples with different HCT or generated blood samples from dilution.  
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From the results of pilot measurements the bigger phase in this thesis which is the second 
phase known as “research measurements” phase is learned and carried out. In second phase 33 
human blood samples are used.                                                                                                                                                                                                                                                     
 
 5.1 Dry measurements: Impedance measurements using Microtest impedance analyzer 
and tissue simulator 
 
This section demonstrates the equipment that are used in performing the dry measurements in 
phase one. 
 
 
5.1.1 Microtest impedance analyzer 
 
First part of experiments is done in the Material Lab at the faculty of Engineering at Al-Quds 
University as all the needed equipment and instruments are located in that site. In this part, the 
impedance instrument that is used is a Multi Frequency Impedance Analyzer Microtest 6379 . 
 
The specifications of this impedance analyzer are shown in the following table, (see this 
equipment in figure 5.1). 
Table 5.1: Impedance Analyzer Specifications . 
Measurement parameters 
 
｜Z｜,｜Y｜,θ, R, X, G, B, L, C, Q, D, ESR, DCR measurement 
 
Circuit Series/Parallel 
Test Frequency 6379 
20Hz ~ 10MHz 
 
Frequency Step 
Resolution 
 
5 Digits 
Frequency Accuracy 
 
±0.01% 
Measurement Range ｜Z｜ R X  0.1 mΩ ~ 100MΩ 
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Figure 5.1: Multi Frequency Impedance Analyzer . 
 
 
 
5.1.2 Biological tissue simulator 
 
Before using a biological tissue to be studied by using the above mentioned instrument, a 
Biological tissue simulator is used –Figure 5.2. This simulator which is a model for biological 
tissue acts as biological tissue. Those simulators are used in order to check the validity of the 
measurements. The theoretical values for the impedance module and phase angle for the tissue 
simulator is shown in table 5.2. 
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Figure 5.2: Biological Tissue Simulator . 
 
Figure 5.3 shows the schematic circuit of the used biological tissue simulator. 
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Figure 5.3: Biological Tissue Simulator Schematic Circuit . 
 
 
Table 5.2 shows the theoretical values for impedance module and phase angle from the tissue 
simulator. 
Table 5.2: Theoretical values for impedance module and phase angle from the tissue simulator  
Impedance Module (Ω)Theoretical value Phase angle (deg) Theoretical value 
10kHz 48.805 10kHz -3.450 
20kHz 47.293 20kHz -5.522 
50kHz 43.697 50kHz -7.197 
100kHz 40.655 100kHz -7.426 
220kHz 37.745 220kHz -6.065 
500kHz 36.049 500kHz -3.585 
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5.2 Results from Dry Measurements\Phase One 
 
The measurements setup is shown in figure 5.4.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Complete Connection between Multi Frequency Impedance Analyzer Tissue simulator . 
 
The impedance analyzer is attached to the tissue simulator  and the impedance module and 
phase are continuously recorded at 6 frequencies (10,20,50,100,220,500 kHz) with Sampling 
Rate SR= 3 samples/min. The measured data is shown in tables 5.3 and 5.4. The data is 
acquired and transferred to the computer and analyzed using MATLAB. The measured 
impedance is fitted to Cole-Cole model.  
 
Figure 5.4 shows one sample of the measured impedance plotted in the complex plan -Real(Z) 
Vs Img(Z). The 6 small circles represents the measured impedance data at 6 frequencies and 
the solid line is the Cole-Cole model. Excellent fitting can be observed for the measured data 
on the Cole-Cole mathematical model.  
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Figures 5.5 and 5.6 show the impedance module and the phase angle plotted as function of 
frequency.  The 6 small circles represents the measured data at 6 frequencies and the solid line 
is the Cole-Cole model. 
 
 As you can notice from those figures that there is an excellent fitting to the Cole-Cole 
mathematical model. But you can see that the last reading at the frequency 500KHz has a bad 
fitting to Cole-Cole mathematical model, that limits the measurements to be done at the 
selected range of frequencies (10,20,50,100,220,500 kHz). Fitting needs three readings but 
here six readings are taken then the readings at the rest of frequencies can be found using 
Cole-Cole mathematical model. 
 
 
Tables 5.3 and 5.4 show the first results: 
Table 5.3: Measured Impedance module at 6 frequencies . 
Reading 10kHz 20kHz 50kHz 100kHz 220kHz 500kHz 
1 49.34 47.8 44.26 41.36 38.8 36.77 
2 49.34 47.79 44.26 41.36 38.8 36.77 
3 49.34 47.79 44.26 41.36 38.8 36.77 
4 49.34 47.79 44.26 41.36 38.8 36.77 
5 49.35 47.8 44.26 41.36 38.8 36.77 
6 49.34 47.79 44.26 41.36 38.8 36.77 
7 49.35 47.79 44.26 41.36 38.8 36.77 
8 49.35 47.79 44.26 41.36 38.8 36.77 
9 49.35 47.8 44.26 41.36 38.8 36.77 
10 49.34 47.8 44.26 41.36 38.8 36.77 
 
Table 5.4: Measured Phase module at 6 frequencies . 
Reading 10kHz 20kHz 50kHz 100kHz 220kHz 500kHz 
1 -3.19 -5.12 -6.86 -6.88 -5.75 -2.71 
2 -3.19 -5.12 -6.85 -6.88 -5.75 -2.71 
3 -3.19 -5.12 -6.86 -6.88 -5.75 -2.71 
4 -3.19 -5.12 -6.86 -6.88 -5.75 -2.71 
5 -3.19 -5.12 -6.86 -6.88 -5.75 -2.71 
6 -3.19 -5.12 -6.86 -6.88 -5.75 -2.71 
7 -3.19 -5.12 -6.86 -6.88 -5.75 -2.7 
8 -3.19 -5.12 -6.86 -6.88 -5.75 -2.71 
9 -3.19 -5.12 -6.86 -6.88 -5.75 -2.7 
10 -3.19 -5.12 -6.86 -6.88 -5.75 -2.71 
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In order to verify the results, the average of the ten measured impedance and phase angle are 
found at the six frequencies. Then those values are compared to the theoretical ones by finding 
the absolute error as shown in tables 5.5 and 5.6: 
 
Table 5.5: Relative Error of the measured Impedance module at 6 frequencies . 
Reading  10kHz  20kHz  50kHz  100kHz  220kHz  500kHz  
Average 
Value (Ω)  
49.344 47.794 44.26 41.36 38.8 36.77 
Theoretical 
Value (Ω)  
48.805  47.293  43.697  40.655  37.745  36.049  
Absolute 
Error  
0.539  0.501  0.563  0.705  1.055  0.721  
  
 
Table 5.6: Relative Error of the measured Phase Angle at 6 frequencies . 
Reading  10kHz  20kHz  50kHz  100kHz  220kHz  500kHz  
Average 
Value (deg)  
-3.19 -5.12 -6.859 -6.88 -5.75 -2.708 
Theoretical 
Value (deg)  
-3.45 -5.522  -7.197  -7.426  -6.065  -3.585  
Absolute 
Error  
0.26  0.402  0.338  0.546  0.315  0.877  
 
 
The relative error of the measured impedance and phase angle compared to the theoretical 
values are very small. This result verify the accuracy of the used instrument. 
 
If one reading from the 10 measured readings is fitted to Cole-Cole model, the following 
graph will be obtained:  
 
 
 
 34 
 
 
Figure 5.5: One sample of the measured impedance in the complex plane .  
 
The small 6 circles on the curve in figure 5.5 represents the measured data at the six 
frequencies mentioned previously where the solid line represents Cole-Cole mathematical 
model. What can be observed from that figure is the best fitting of the measured data to Cole-
Cole model. 
The same result can be noticed if the impedance module and the phase angle for one reading 
of the 10 readings are fitted to Cole-Cole model (see figures 5.6 and 5.7). 
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Figure 5.6: Impedance Module as function of frequency . 
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Figure 5.7: Phase Angle as function of frequency . 
 
 
What can be noticed from figures 5.6 and 5.7 is the excellent fitting of the measured 
impedance and phase angle to Cole-Cole model. But increasing the frequency above 500KHz 
has noisy results as the fitting to Cole-Cole model becomes bad. Therefore those six 
frequencies are chosen to take bioimpedance measurements upon. 
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5.3 Wet measurements: Impedance measurements using Local Impedance analyzer and 
blood tissue samples 
 
The second set of measurements in the first phase are wet measurements with 10 blood 
samples using Local tissue impedance analyzer. 
 
5.3.1 Blood Sample Preparation  
 
A sample of 100 cm
3
 of fresh human blood is collected from a healthy subject. The sample is 
analyzed  using conventional clinical cell counter - CBC instrument- to evaluate the sample 
Haematocrit HCT. The sample is found to have HCT=43.1% or 0.431. 
 
The blood sample is divided into two portions each of 50 cm
3
. The first portion is centrifuged 
using a bench top centrifuge at speed of 3500 RPM for 10  minutes in order to separate  
plasma from blood cells. Plasma is then collected and used for blood dilution.  
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5.3.2 Blood Chamber and Impedance Probe 
 
The blood chamber and impedance probes are designed by Dr. Surkhi. The blood chamber and 
the impedance probes are shown in the figures 5.8 & 5.9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: The blood chamber and impedance probe . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: The blood chamber and impedance probe . 
 
The blood chamber that is used has a cylindrical shape with the following parameters: 
 
 Inner diameter = 2.8cm 
Inner cross-section area = 6.157cm
2
 
Length( distance  between the probes) = 2.2cm 
+
V 
-V 
+I -I 
Blood 
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Total chamber volume = 13.6cm
3
 
 
Four circular shaped impedance probes are designed as shown in figure 5.8. Two of them for 
current injection (Blue) and the others for the voltage detection (Red). 
 
The blood is injected into the chamber and the impedance is measured via the four probes. Ten 
Different blood samples are produced with different Haematocrit values. Samples are obtained 
by removing 1 cm
3
 of blood from the chamber and inserting a 1 cm
3
 of plasma dilution then 
the chamber is shaken well, this process is done in order to obtain more than one sample as a 
small blood sample is obtained at the first time. The Haematocrit for each sample is evaluated 
using conventional Clinical Cell Counter - CBC instrument. All measurements are performed 
at temperature of 37°C. 
 
The theoretical value of the blood Haematocrit for each sample is evaluated using the 
following information : Initial sample HCT, volume of the blood Chamber, removed blood 
volume and the volume of the added plasma dilution.    
 
The Haematocrit (HCT) is calculated theoretically by using the following criteria: 
 
RBC(i) = HCT(i − 1) × 12.6 (cm3) 
 
Eq(5.1) 
 
Plasma (i) = 13.6 (cm3) − RBC(i) (cm3) 
 
Eq(5.2) 
 
HCT(i) =  
RBC(i) 
Plasma (i) + RBC(i)
 
 
Eq(5.3) 
 
 
Where: 
 i = 1,2… 10: sample number 
RBC(i): volume of the Red blood cells in sample (i) (cm3) 
Plasma (i): volume of plasma in sample (i) (cm3) 
HCT(i): Haematocrit of sample(i) 
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HCT(0) = 0.431 
 
Note that the above criteria for calculating HCT depends upon the values of RBC(i) and 
Plasma(i). RBC(i) depends upon the value of HCT for previous sample before generating a 
new one by dilution HCT(i − 1) and the chamber volume after taking 1cm3 = 12.6 (cm3). 
Plasma(i) depends upon the total chamber volume 13.6 (cm3) and the value RBC(i). This 
criteria is derived according to the blood chamber design and the process of generating blood 
samples by dilution.  
 
 
 
5.3.3 Local tissue Impedance Spectroscopy System 
 
A multi-frequency impedance analyzer with four electrode configuration is used. The 
Performance tests performed on this analyzer gave excellent results in the following range: 
Module range: 5()  |Z|  200()  2.0%:, Phase range: 0.5(deg)  ||  90(deg)  2.0%, 
Frequency range: 10 kHz-1MHz.  The impedance analyzer is attached to the blood chamber 
and the impedance module and phase are continuously recorded at 6 frequencies 
(10,20,50,100,220,500 kHz) with Sampling Rate SR= 20 samples/minute. Data is acquired 
and transferred to the computer using LABVIEW self designed program –Figure 5.10.  
 
As known LABVIEW is a graphical programming environment used by millions of engineers 
and scientists to develop sophisticated measurement, test, and control systems using intuitive 
graphical icons and wires that resemble a flowchart. It offers unrivaled integration with 
thousands of hardware devices and provides hundreds of built-in libraries for advanced 
analysis and data visualization – all for creating virtual instrumentation. 
You can see the experimental setup in figure 5.10. 
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Figure 5.10: The Experimental setup . 
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5.3.4 Measurement software 
 
Figure 5.11 shows the self-designed LABVIEW program that is designed for acquiring data 
and transferring it to the computer. By using this program you can determine the value of the 
used frequency from the frequency list, the wanted maximum points on the curves, the used 
port. After running this program both Amplitude and phase graph are obtained related to the 
impedance measurement. The program gives you the ability to save your work, stop working 
or exit from the program (see figure 5.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: Data Acquiring program . 
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5.4 Results from Wet Measurements\Phase One 
 
In this section, the results from the 10 blood samples that are produced in wet measurements 
included in phase one are demonstrated. Table 5.7 shows the theoretical and the measured 
HCT for those 10 blood samples. 
Table 5.7: Theoretical & Measured HCT . 
 
Sample HCT Measured HCT Theoretical 
sample0 0.431 0.431 
sample 1 0.410 0.399 
sample 2 0.400 0.370 
sample 3 0.390 0.343 
sample 4 0.309 0.318 
sample 5 0.284 0.294 
sample 6 0.263 0.273 
sample 7 0.236 0.253 
sample 8 0.184 0.234 
sample 9 0.160 0.217 
sample 10 0.133 0.201 
 
 
If the above results are drawn in order to compare between the theoretical and the measured 
HCT, the following figure will be obtained: 
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Figure 5.12: Theoretical and Measured HCT for the 10 blood samples . 
 
The theoretical values for HCT are obtained according to the listed criteria above (Eq(5.1), 
Eq(5.2) and Eq(5.3)) using the total chamber volume, the dilution amount and HCT initial 
value. The HCT measured values are obtained by measuring HCT for each new sample after 
dilution is made using the clinical instrument-CBC.  
 
Table (5.7) and figure (5.12) show HCT theoretical and measured values. As noticed the 
values of HCT drops quickly, thus will affect the values of the measured impedance as will be 
seen later. When the plasma is added thus means more conducting media is added and the 
sample becomes a plasma rich sample instead of the blood cells so the plasma increased and 
hence the value of HCT will be decreased. Thus may result from the volume of the removed 
blood sample from each sample. For future work a small volume of blood smaller than 1cm
3
 
will be removed or the dilution must be made very slow or multi blood samples may be used 
instead of producing blood samples by dilution.. 
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5.4.1. Measured Data: 
For each blood sample, both impedance module and phase are continuously recorded at 6 
frequencies which are (10,20,50,100,220,500 kHz). An example of the recorded data is shown 
in figure 5.13 for blood sample 02. 
 
 
Figure 5.13: Impedance module and Phase angle at 6 frequencies for Sample 02 . 
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5.4.2 Cole-Cole model fitting 
 
The measured impedance at 6 frequencies (round circle on the curve) is fitted into Cole-Cole 
mathematical model (Eq(3.6)) (solid line on curve) using a special program developed using 
MATLAB.  For example figure 5.14-a shows all data in sample02 fitted into Cole-Cole model 
and plotted in the complex plane i.e real part of the impedance vs. the imaginary part. 
Excellent fit with the model can be noticed.  
 
Figure 5.14-b shows the average impedance data of sample 02 plotted in the complex plane. 
The limiting values at low and high frequencies, R0 and R, are not measurable in practice, but 
they can be extrapolated from the mathematical model. 
 
 
 
 
Figure 5.14: Impedance plotted in the complex plane for Sample 02. (a) All measured data (b) Data Average . 
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The bioimpedance measurement is done for each blood sample for about 8 minutes with 
10sample/Minute, so there is nearly 70-80 readings for each blood sample. If the readings 
average of two blood samples with different HCT are taken and fitted to Cole-Cole model, the 
effect of α and resistivity can be noticed (see figure 5.15).  
 
 
 
Figure 5.15: Impedance plotted in the complex plane for sample02(HCT=0.4) and sample04(HCT=0.3) .  
 
Figure 5.15 shows the average readings for sample02 and sample04 fitted to Cole-Cole model. 
The two samples differ in HCT values with 0.4 for sample02 and 0.3 for sample04. Sample04 
is obtained by adding more conducting media -plasma- to sample03 and sample03 is obtained 
by adding more conducting media to sample02. Adding more conducting media will decrease 
the resistivity. Therefore the impedance will be decreased, this result is noticed from figure 
5.15. sample04 has less impedances values than sample02, also the depression of the arc and 
the effect of α can be noticed. 
 
The preliminary data analysis in wet measurements includes: 
1. Cole-Cole parameters extrapolation (R0 and R∞). 
2. ECW and ICW estimation based on first and second generation Xitron estimators. 
3. Blood HCT estimation based on first and second generation Xitron estimators. 
 
 
Sample02 
Sample04 
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Table 5.8 shows Cole-Cole parameters. 
 
Table 5.8: Cole-Cole Parameters . 
 Ro R fc alfa 
Original blood simple 60.52 32.76 7.93E+05 0.17 
Sample 1 57.65 32.11 7.79E+05 0.18 
Sample 2 52.57 31.56 1.02E+06 0.22 
Sample 3 24.23 19.78 4.18E+05 0.03 
Sample 4 42.08 26.55 1.33E+06 0.28 
Sample 5 20.47 17.90 3.05E+05 0.06 
Sample 6 18.63 16.78 2.56E+05 0.10 
Sample 7 17.41 15.81 2.15E+05 0.21 
Sample 8 16.47 15.16 1.01E+05 0.30 
Sample 9     
Sample 10     
 
 
Table 5.9 shows high frequency ICW Estimator 
Table 5.9: High Frequency ICW Estimator. 
Sample 
Theoretical 
V
ICW
(Cm
3
) 
Measured 
V
ICW
(Cm
3
) 
Xitron 
First Gen. 
V
ICW
(Cm
3
) 
Xitron Second 
Gen. 
V
ICW
(Cm
3
) 
Original blood sample 5.86 5.86 9.48 7.65 
Sample 1 5.43 5.58 9.33 7.44 
Sample 2 5.03 5.44 8.91 6.86 
Sample 3 4.66 5.30 6.52 3.68 
Sample 4 4.32 4.20 8.60 6.44 
Sample 5 4.00 3.86 5.78 2.73 
Sample 6 3.71 3.58 5.43 2.29 
Sample 7 3.43 3.21 5.33 2.15 
Sample 8 3.18 2.50 5.17 1.95 
Sample 9 2.95 2.18 4.12 1.04 
Sample 10 2.73 1.81 5.38 2.22 
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5.5 Conclusions from Phase One 
 
Blood Haematocrit is the volumetric percentage of blood cells to the total blood volume.  In 
the case of blood tissue, the volume of blood cells is the VICW  while the volume of plasma is 
the volume VECW . 
 
Thus the relation between the HCT and VICW  and VECW   can be written as: 
  
HCT =
VICW
(VICW + VECW )
 
 
Eq(5.4) 
Or: 
 
HCT =
1
(1 + VECW /VICW )
 
 
Eq(5.5) 
Note: Eq(5.5) is obtained by dividing Eq(5.4) by VICW  . 
 
 
Using the first and second generations for VICW /VECW  as a relation to Ro and R∞ ,the blood 
HCT can be evaluated based on those estimators. 
 
The HCT for blood sample is calculated using both the first and second generation of Xitron 
ICW and ECW estimators. The following table shows those values with the theoretical ones. 
Table 5.10: High Frequency ICW Estimator. 
Sample 
HCT 
Theoretical 
HCT 
First Gen 
HCT 
Second Gen 
Original blood sample 0.431 0.70 0.56 
Sample 1 0.399 0.69 0.55 
Sample 2 0.370 0.65 0.50 
Sample 3 0.343 0.48 0.27 
Sample 4 0.318 0.63 0.47 
Sample 5 0.294 0.42 0.20 
Sample 6 0.273 0.40 0.17 
Sample 7 0.253 0.39 0.16 
Sample 8 0.234 0.38 0.14 
Sample 9 0.217 0.30 0.08 
Sample 10 0.201 0.40 0.16 
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The results for blood sample02 is shown in the following figure: 
 
 
 
Figure 5.16: Haematocrit Value by First and Second Generation for sample02 . 
 
Referring to Table 5.7 which includes the measured and theoretical HCT values for 10 blood 
samples obtained by dilution, HCT(sample02)=0.4 (measured) and 0.37(theoretical). From 
figure (5.15), it is noticed that both Xitron first and second generations give overestimation for 
the Haematocrit value of sample02, but the overestimation in the first generation is more than 
that in the second generation, so the second generation gives us more realistic results than the 
first one and thus the second generation is the development and enhancement of the first one; 
therefore there is a relationship between the HCT value and the Bioimpedance measurements. 
 
From the pilot measurements some points may be concluded as: 
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• In dry measurements, no significant differences between the measured impedance of 
tissue simulator and the theoretical values which indicates excellent accuracy of the 
instrument. 
• In wet measurement, both instruments are able to measure bioimpedance of blood. 
• In wet measurements as HCT is reduced below 30%, data are not measured as 
bioimpedance data and had bad fitting to Cole-Cole model. In general ,the error in 
estimating  HCT value increased as the HCT values decreased so multi blood samples 
must be used and not diluted samples. 
• In wet measurement, the estimated  HCT value based on the first and second Xitron 
estimators had significant errors compared to  the measured or the theoretical HCT 
values. 
• The first and second generation of volume estimation give us overestimation of ICW 
volume values but second generation results are better than first generation as first 
generation gives more overestimation than second one. 
• Blood chamber size is good. 
• The used six frequencies are also fine. 
• From the results of phase one, we decided to use Local Impedance Analyzer 
Instrument. 
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Chapter Six: Phase Two Measurements and Results (Research 
Measurements) 
 
6.1 Blood Samples 
 
In this phase 33 human fresh blood samples not diluted (multi blood samples) are used. Many 
parameters will be investigated such as the extracellular and intracellular water and 
Haematocrit. Samples will be taken and measured by using Local Impedance Analyzer 
equipment at the material lab (Al-Quds University). The used blood chamber is the same as 
used in phase one. The frequencies that are used to do measurements are the same as phase 
one (10,20,50,100,220 and 500 kHz). In this phase three estimators are used to make 
comparison and data analysis (Xitron first, second generation and Surkhi Estimator). 
 
Before testing the blood sample at Al-Quds University, the same sample is previously 
investigated using Clinical Blood Analyzers at the Hospital from which the blood is collected. 
After testing the blood sample at the material lab the same blood sample will be tested again 
using Clinical Blood Analyzer at the medicine school at Al-Quds university in order to 
compare the results. 
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6.2 Phase Two Objectives 
 
The initial research questions that may be asked to introduce the problem statement include: 
 
 How to estimate water content inside cells and outside cells ?  
 Is this possible to do using bioimpedance measurements ? 
 Can Blood Haematocrit HCT using bioimpedance measurements be estimated ?  
 
From those initial research questions; research objectives can be guessed and introduced and 
can be summarized in the following points: 
 
1. Perform Electrical Bioimpedance spectroscopy measurements using wide frequency 
range on biological tissues, mainly blood tissues. 
2. Evaluate tissue parameters out of the Bioimpedance measurements such as : 
• Intracellular water volume  
• Extracellular water volume  
• Blood Haematocrit HCT 
3. Study and compare the most used ICW and ECW estimators available in literature  
4. Study the accuracy of ICW and ECW estimators and try to indicate source of 
inaccuracies. 
5. Develop new ICW and ECW estimators . 
6. Study the Cole-Cole parameters of the used blood samples.  
 
After introducing the objectives from this work, the possible contribution and expected 
outcomes from the work may be predicted as follows: 
 
1. Measure the intracellular and extracellular water content in the tissue based on low and 
high frequency measurements. 
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2. Different ECW and ICW estimators are currently used, many authors have reported 
inaccuracies in these estimators and errors in their results therefore different estimators 
will be compared, analyzed and corrected . 
3. Develop blood Haematocrit HCT estimator based on high frequency impedance 
measurements. 
 
In order to achieve the desired goals and objectives from this work, let us remember that pilot 
study and measurements are done to crystallize the idea and find out any directions, 
measurements or procedure that can be chosen and to check the possibility for application. 
 
From the pilot study and measurements that are done previously, some points are taken in 
considerations which are: 
 
• In dry measurements, no significant differences between the measured impedance of 
tissue simulator and the theoretical values which indicates excellent accuracy of the 
instrument. 
• In wet measurement, the estimated  HCT value, based on the first and second Xitron 
estimators, had significant errors compared to the measured or the theoretical HCT 
values. 
• In general, the error in estimating  HCT value increases as the HCT value decreases. 
• HCT  dropped sharply as 1 cm3 of blood volume is taken from the sample and replaced 
by plasma to take different HCT reading. Hence a small volume smaller than 1 cm
3
 
must be taken or multi blood samples may be used. 
• The first and second generations of volume estimation give us overestimation of ICW 
volume values.  
From previous points control and limitations of this work is known and may be summarized in 
the following points: 
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• In Wet Measurements, the HCT values dropped sharply, so a small volume of blood 
smaller than 1 cm
3
  must be taken in order to take different measurements or multi 
blood samples may be replaced instead of generating blood samples using dilution. 
• When the HCT is reduced in the sample, then the noise is expected to increase and thus 
will affect the measurements. Measurements had very bad fitting to Cole-Cole model 
due to reduced amount of cells.  
From all previous measurements limitations and controls, guidelines can now be drawn in 
order to achieve the goals and objectives of this work as follows: 
 
• Indicate source of errors in Xitron estimators  
• Develop ICW and ECW estimator 
• Increase the frequency range up to MHz 
• Work on more blood samples with HCT range between the physiological values 50-
25% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
 
6.3 Phase Two Experimental Procedure 
 
This section describes the procedure with which the results are collected.  
 
To obtain blood samples that are well tested, hospital management department has been 
addressed by the administration of faculty of engineering and the thesis supervisor. Hospital 
management department addresses Hebron Governmental Hospital (HGH) in order to 
facilitate the task and obtain the required blood samples. Then blood samples are measured in 
material lab at Al-Quds University with different steps that are discussed briefly below. 
 
About 33 blood samples are collected from Hebron Governmental Hospital, all blood samples 
are fresh and well tested. The following steps are done to each one of the collected blood 
samples: 
 
1. The blood sample is taken from blood bank at HGH. The sample of 40-45 cm3 is fresh 
and well tested. Clinical tests include HBSAy, HIV, HCV. Those clinical tests must be 
negative for the blood sample and those results can be checked from blood bank 
records. 
2. By using the spectroscopy equipment at HGH, all related blood tests are done 
including HCT. 
3. After that the blood sample kept cool to maintain a suitable blood temperature and to 
be transported from HGH at Hebron to Al-Quds University without damaging the 
blood cells. 
4. After nearly one hour, the blood sample arrived to the Material laboratory in Al-Quds 
University. 
5. Prepare the blood sample for measurements by shaking it for about 10 minutes using 
the shaker (See figure 6.1). 
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Figure 6.1: Blood Samples on the shaker . 
 
6. Taking into account all the safety requirements during the work with blood sample in 
the laboratory by wearing lab coat, gloves and taking the considerations to obtain the 
cleaning of everything used. 
7. After 10 minutes, a syringe is used to fill chamber C with blood. 
 
Figure 6.2: A Blood Sample in the chamber . 
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8. Using the local tissue analyzer, injection and detection electrodes and the labview 
acquiring program to record the impedance and phase angle result at different 
frequencies. 
 
Figure 6.3: Connecting chamber with frequency analyzer electrodes . 
 
9. Save the data. 
10. Taking the blood sample to medicine college in order to measure its Haematocrit by 
using the centrifuge equipment at the medicine laboratory. 
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Figure 6.4: Haematology Analyzer . 
 
By using the capillary tubes, the technician take an amount of the blood sample after shaking 
it and put it in the centrifuge equipment, indicating RPM and centrifuge time. Usually 1300 
rpm and 5 minutes are taken as parameters. 
 
Figure 6.5: Capillary Tubes . 
 
11. Record the Haematocrit value in order to compare it with the one that the hospital 
equipment had measured and the estimated value that will be estimated. 
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12. Returning to the data file that is saved, this file include readings of impedance and 
phase at different frequencies determined by the labview acquiring program.  
13. By using matlab program a matlab code is written in order to estimate the Haematocrit 
value based on Xitron first and second generation therefore compare those values with 
the values obtained in hospital and university, absolute error and relative error are 
calculated. 
14. The Cole-Cole parameters are extrapolated for each blood sample. 
15. Extracellular and intracellular volumes are calculated at low and high frequency based 
on Xitron first and second generation. 
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6.4 Phase Two: Results 
 
According to the research measurements procedure mentioned above and by using the 
equations of the used and developed estimators, this section presents the results that are 
obtained for Haematocrit, Volumes Estimation and Cole-Cole parameters. 
 
6.4.1 Haematocrit Estimators 
 
The first results obtained are the values of HCT depending upon Xitron first generation, 
Xitron second generation and the developed Surkhi estimator. This section shows those 
results. 
 
6.4.1.1. Xitron First Generation: 
 
Table 6.1 shows the results of the first generation estimator used by Xitron impedance systems 
company for the 33 blood samples. In that table the values of HCT measured in hospital and 
university are shown, add to that the values of HCT using first generation equation are 
calculated, then absolute and relative errors are determined.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 62 
 
 
 
Table 6.1: First Generation Results . 
Sample# Sample 
Hospital 
HCT 
University 
HCT 
First Generation 
HCT 
Abs. Error 
1st Gen. Relative 
Error (%) 
1 sample00 46.5 46 68.344±0.009 22.344 -48.574 
2 sample05 43.3 42.5 67.700±0.011 25.200 -59.294 
3 sample066 43 43.5 67.061±0.012 23.561 -54.163 
4 sample06 43.4 43.5 68.470±0.010 24.970 -57.402 
5 sample07 47.6 45.5 67.843±0.011 22.343 -49.105 
6 sample08 40.7 34 64.859±0.026 30.859 -90.762 
7 sample09 47 43 70.614±0.025 27.614 -64.219 
8 sample10 42 42 66.969±0.020 24.969 -59.450 
9 sample11 45.8 42.5 65.950±0.017 23.450 -55.176 
10 sample12 52.9 43 67.246±0.016 24.246 -56.386 
11 sample13 34 32 55.970±0.028 23.970 -74.906 
12 sample14 42 40 65.731±0.017 25.731 -64.328 
13 sample15 40 37.5 64.215±0.025 26.715 -71.240 
14 sample16 58 58 75.244±0.051 17.244 -29.731 
15 sample17 39 37 64.205±0.032 27.205 -73.527 
16 sample18 48 47 68.722±0.027 21.722 -46.217 
17 sample19 39 38 62.461±0.016 24.461 -64.371 
18 sample20 51 51 70.600±0.035 19.600 -38.431 
19 sample21 40 38.5 63.932±0.020 25.432 -66.057 
20 sample22 58 57.5 75.796±0.044 18.296 -31.819 
21 sample23 31.6 32 58.319±0.077 26.319 -82.247 
22 sample24 35.7 35 57.517±0.075 22.517 -64.334 
23 sample25 41.5 41 60.132±0.065 19.132 -46.663 
24 sample26 42.3 40 61.373±0.059 21.373 -53.433 
25 sample27 38.6 40 59.717±0.064 19.717 -49.293 
26 sample28 24.9 25 47.347±0.118 22.347 -89.388 
27 sample4e 46 45 67.696±0.059 22.696 -50.436 
28 
sample 
1_old 
43 39.9 68.610±0.042 28.710 -71.955 
29 
sample 
2_old 
40 37 50.462±0.049 13.462 -36.384 
30 
sample 
3_old 
38 34.3 65.623±0.056 31.323 -91.321 
31 
sample 
4_old 
39 31.8 63.204±0.064 31.404 -98.755 
32 
sample 
5_old 
35 29.4 62.266±0.093 32.866 -111.789 
33 
sample 
6_old 
33 27.3 59.942±0.127 32.642 -119.568 
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6.4.1.2. Xitron Second Generation: 
 
Table 6.2 shows the results of the second generation estimator used by Xitron impedance 
systems company for the 33 blood samples. In that table the values of HCT measured in 
hospital and university are shown, add to that the values of HCT using second generation 
equation are calculated, then absolute and relative errors are determined 
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Table 6.2: Second Generation Results . 
Sample# Sample Hospital HCT University HCT 
Second Generation 
HCT 
Abs. Error 
2nd Gen. 
Relative 
Error (%) 
1 sample00 46.5 46 54.369±0.012 8.369 -18.200 
2 sample05 43.3 42.5 53.48±0.015 10.98 -25.835 
3 sample066 43 43.5 52.607±0.016 9.107 -20.936 
4 sample06 43.4 43.5 54.542±0.013 11.042 -25.384 
5 sample07 47.6 45.5 53.68±0.015 8.18 -17.978 
6 sample08 40.7 34 49.597±0.036 15.597 -45.874 
7 sample09 47 43 57.502±0.035 14.502 -33.726 
8 sample10 42 42 52.481±0.027 10.481 -24.955 
9 sample11 45.8 42.5 51.085±0.024 8.585 -20.200 
10 sample12 52.9 43 52.861±0.023 9.861 -22.933 
11 sample13 34 32 37.642±0.038 5.642 -17.631 
12 sample14 42 40 50.787±0.023 10.787 -26.968 
13 sample15 40 37.5 48.721±0.035 11.221 -29.923 
14 sample16 58 58 63.957±0.070 5.957 -10.271 
15 sample17 39 37 48.708±0.045 11.708 -31.643 
16 sample18 48 47 54.889±0.037 7.889 -16.785 
17 sample19 39 38 46.342±0.022 8.342 -21.953 
18 sample20 51 51 57.483±0.048 6.483 -12.712 
19 sample21 40 38.5 48.336±0.027 9.836 -25.548 
20 sample22 58 57.5 64.733±0.061 7.233 -12.579 
21 sample23 31.6 32 40.771±0.105 8.771 -27.409 
22 sample24 35.7 35 39.7±0.103 4.7 -13.429 
23 sample25 41.5 41 43.201±0.089 2.201 -5.368 
24 sample26 42.3 40 44.872±0.081 4.872 -12.180 
25 sample27 38.6 40 42.645±0.088 2.645 -6.613 
26 sample28 24.9 25 26.326±0.158 1.326 -5.304 
27 sample4e 46 45 53.478±0.080 8.478 -18.840 
28 sample 1_old 43 39.9 54.735±0.058 14.835 -37.180 
29 sample 2_old 40 37 50.462±0.068 13.462 -36.384 
30 sample 3_old 38 34.3 50.64±0.077 16.34 -47.638 
31 sample 4_old 39 31.8 47.348±0.088 15.548 -48.893 
32 sample 5_old 35 29.4 46.079±0.121 16.679 -56.731 
33 sample 6_old 33 27.3 42.947±0.166 15.647 -57.315 
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6.4.1.3. Developed Surkhi Estimator Results: 
 
Table 6.3 shows the accuracy of the developed Surkhi estimator according to this work for 
the 33 blood samples. In that table the values of HCT measured in hospital and university 
are shown, add to that the calculated values of HCT using Surkhi Estimator equation 
(equation 4.14), then absolute and relative errors are determined.  
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Table 6.3: Developed Surkhi Estimator Results . 
Sample# Sample 
Hospital 
HCT 
University 
HCT 
Surkhi HCT Abs. Error 
Surkhi Estimator 
Relative Error 
(%) 
1 sample00 46.5 46 48.511±0.012 2.511 -5.459 
2 sample05 43.3 42.5 47.59±0.015 5.090 -11.976 
3 sample066 43 43.5 46.701±0.016 3.201 -7.359 
4 sample06 43.4 43.5 48.689±0.014 5.189 -11.929 
5 sample07 47.6 45.5 47.802±0.015 2.302 -5.059 
6 sample08 40.7 34 43.637±0.036 9.637 -28.344 
7 sample09 47 43 51.76±0.036 8.760 -20.372 
8 sample10 42 42 46.572±0.028 4.572 -10.886 
9 sample11 45.8 42.5 45.147±0.024 2.647 -6.228 
10 sample12 52.9 43 46.961±0.022 3.961 -9.212 
11 sample13 34 32 31.8±0.036 -0.200 0.625 
12 sample14 42 40 44.844±0.023 4.844 -12.110 
13 sample15 40 37.5 42.751±0.035 5.251 -14.003 
14 sample16 58 58 58.577±0.073 0.577 -0.995 
15 sample17 39 37 42.738±0.046 5.738 -15.508 
16 sample18 48 47 49.048±0.037 2.048 -4.357 
17 sample19 39 38 40.361±0.022 2.361 -6.213 
18 sample20 51 51 51.74±0.049 0.740 -1.451 
19 sample21 40 38.5 42.363±0.027 3.863 -10.034 
20 sample22 58 57.5 59.408±0.063 1.908 -3.318 
21 sample23 31.6 32 34.848±0.107 2.848 -8.900 
22 sample24 35.7 35 33.801±0.104 -1.199 3.426 
23 sample25 41.5 41 37.239±0.091 -3.761 9.173 
24 sample26 42.3 40 38.896±0.083 -1.104 2.760 
25 sample27 38.6 40 36.69±0.090 -3.310 8.275 
26 sample28 24.9 25 21.066±0.156 -3.934 15.736 
27 sample4e 46 45 47.594±0.081 2.594 -5.764 
28 sample 1_old 43 39.9 48.889±0.060 8.989 -22.529 
29 sample 2_old 40 37 44.514±0.070 7.514 -20.308 
30 sample 3_old 38 34.3 44.694±0.079 10.394 -30.303 
31 sample 4_old 39 31.8 41.369±0.090 9.569 -30.091 
32 sample 5_old 35 29.4 40.098±0.119 10.698 -36.388 
33 sample 6_old 33 27.3 36.988±0.161 9.688 -35.487 
 67 
 
6.4.1.4. Comparison between Used and Developed Estimators: 
 
Now let us make a compartment between the most used estimators which are Xitron First 
and Second Generation and the developed Surkhi Estimator for determining HCT values. 
 
The following figure shows the relationship between time and HCT for sample15: 
Figure 6.6: Haematocrit Value by First and Second Xitron Generation and Surkhi Estimator for 
sample15. 
 
 
As you can notice from figure (6.6) Xitron first and second generation gives 
overestimation for HCT value which is indicated by the solid gold line (HCT=0.4). First 
generation gives more overestimation than second generation whereas the developed 
Surkhi estimator gives the best and the most nearest value from the theoretical value.  
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Also you can notice that difference from figure (6.7) below. 
 
Figure 6.7: Comparison between Used and Developed Estimator in determining HCT value for sample15. 
 
 
From the tables of determining HCT value by Xitron first, second generation and the 
developed Surkhi estimator, you can notice that the theoretical value for HCT of sample15 
is 40 (Hospital value) and 37.5 (University value). From the above figures you can notice 
the difference between the accuracies of the used and developed estimators.   
 
 
 
 
 
 
 
 
 
 
 
 
ECW: 55%
ICW: 45%
LF Estimator  HTC= 0.4492
ECW: 57%
ICW: 43%
Omar HF Estimator  HTC= 0.42751
ECW: 36%
ICW: 64%
Pere HF Estimator  HTC= 0.64215
ECW: 51%
ICW: 49%
Matthie HF Estimator  HTC= 0.48721
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6.4.2. ECW, ICW Volumes Estimation: 
 
This section presents the theoretical volumes. The volumes are estimated based upon 
Xitron first, second generations and the developed Surkhi Estimator. 
 
6.4.2.1. Theoretical Volumes: 
 
The theoretical volumes are found depending upon the volume of the used chamber and the 
values of HCT for each sample in order to compare the theoretical volumes with the 
estimated ones using Xitron first, second generations and the developed estimator. Table 
6.4 shows those theoretical volumes. 
 
Eq(5.4) describes the relationship between the HCT value and the volumes of Intracellular 
and Extracellular content, so the theoretical volumes can be determined according to the 
HCT value and the used chamber volume as shown in the following equations: 
 
HCT =  
VICW
Total Volume
 
 
Where Total Volume = 13.6 cm
3
. 
Eq(6.1) 
  
VICW = Total Volume × HCT   Eq(6.2) 
 
𝑉𝐸𝐶𝑊 = 𝑇𝑜𝑡𝑎𝑙 𝑉𝑜𝑙𝑢𝑚𝑒 −  VICW   
 
Eq(6.3) 
So using those equations, the theoretical volumes for Intracellular and Extracellular content 
can be determined. 
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Table 6.4: Theoretical Volumes . 
Sample
# 
Sample 
Hospital 
HCT 
University 
HCT 
HCT Mean* 
Blood 
Volume 
Theoretical 
VICW 
Theoretical 
VECW 
1 sample00 46.5 46 46.25 13.6 6.29 7.31 
2 sample05 43.3 42.5 43.25 13.6 5.882 7.718 
3 sample066 43 43.5 43.25 13.6 5.882 7.718 
4 sample06 43.4 43.5 43.45 13.6 5.9092 7.691 
5 sample07 47.6 45.5 46.55 13.6 6.3308 7.269 
6 sample08 40.7 34 37.35 13.6 5.0796 8.520 
7 sample09 47 43 45 13.6 6.12 7.480 
8 sample10 42 42 42 13.6 5.712 7.888 
9 sample11 45.8 42.5 44.15 13.6 6.0044 7.596 
10 sample12 52.9 43 47.95 13.6 6.5212 7.079 
11 sample13 34 32 33 13.6 4.488 9.112 
12 sample14 42 40 41 13.6 5.576 8.024 
13 sample15 40 37.5 38.75 13.6 5.27 8.330 
14 sample16 58 58 58 13.6 7.888 5.712 
15 sample17 39 37 38 13.6 5.168 8.432 
16 sample18 48 47 47.5 13.6 6.46 7.140 
17 sample19 39 38 38.5 13.6 5.236 8.364 
18 sample20 51 51 51 13.6 6.936 6.664 
19 sample21 40 38.5 39.25 13.6 5.338 8.262 
20 sample22 58 57.5 57.75 13.6 7.854 5.746 
21 sample23 31.6 32 31.8 13.6 4.3248 9.275 
22 sample24 35.7 35 35.35 13.6 4.8076 8.792 
23 sample25 41.5 41 41.25 13.6 5.61 7.990 
24 sample26 42.3 40 41.15 13.6 5.5964 8.004 
25 sample27 38.6 40 39.3 13.6 5.3448 8.255 
26 sample28 24.9 25 24.95 13.6 3.3932 10.207 
27 sample4e 46 45 45.5 13.6 6.188 7.412 
28 
sample 
1_old 
43 39.9 
41.45 
13.6 
5.6372 7.963 
29 
sample 
2_old 
40 37 
38.5 
13.6 
5.236 8.364 
30 
sample 
3_old 
38 34.3 
36.15 
13.6 
4.9164 8.684 
31 
sample 
4_old 
39 31.8 
35.4 
13.6 
4.8144 8.786 
32 
sample 
5_old 
35 29.4 
32.2 
13.6 
4.3792 9.221 
33 
sample 
6_old 
33 27.3 
30.15 
13.6 
4.1004 9.500 
 
* HCT Mean: The average value of University and Hospital HCT. 
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6.4.2.2. First Generation Volumes Estimation: 
 
Table 6.5 shows the results related to the volumes estimation depending upon Xitron first 
generation. Note that the volumes at low frequency are the same for all estimators but the 
difference will be in estimating the volumes at high frequencies, so each estimator gives a 
value for the intracellular volume content and so in calculating the extracellular volume. 
 
Table 6.5: Xitron First Generation Volumes Estimation . 
Sample# Sample HCT Mean* VICWLF VECWLF VICWHF VECWHF 
1 sample00 46.25 8.010 5.590 9.295 4.305 
2 sample05 43.25 7.256 6.344 9.207 4.393 
3 sample066 43.25 7.429 6.171 9.12 4.480 
4 sample06 43.45 7.110 6.490 9.312 4.288 
5 sample07 46.55 7.110 6.490 9.227 4.373 
6 sample08 37.35 6.220 7.380 8.821 4.779 
7 sample09 45 7.087 6.513 9.604 3.996 
8 sample10 42 6.863 6.737 9.108 4.492 
9 sample11 44.15 7.007 6.593 8.969 4.631 
10 sample12 47.95 7.098 6.502 9.146 4.454 
11 sample13 33 5.395 8.205 7.612 5.988 
12 sample14 41 6.775 6.825 8.939 4.661 
13 sample15 38.75 6.109 7.491 8.733 4.867 
14 sample16 58 8.646 4.954 10.233 3.367 
15 sample17 38 6.496 7.104 8.732 4.868 
16 sample18 47.5 7.656 5.944 9.346 4.254 
17 sample19 38.5 6.342 7.258 8.495 5.105 
18 sample20 51 8.034 5.566 9.602 3.998 
19 sample21 39.25 6.457 7.143 8.695 4.905 
20 sample22 57.75 8.653 4.947 10.308 3.292 
21 sample23 31.8 6.278 7.322 7.931 5.669 
22 sample24 35.35 6.396 7.204 7.822 5.778 
23 sample25 41.25 6.869 6.731 8.178 5.422 
24 sample26 41.15 6.952 6.648 8.347 5.253 
25 sample27 39.3 6.690 6.910 8.122 5.478 
26 sample28 24.95 4.896 8.704 6.439 7.161 
27 sample4e 45.5 7.256 6.344 9.207 4.393 
28 sample 1_old 41.45 5.740 7.860 9.331 4.269 
29 sample 2_old 38.5 5.242 8.358 8.907 4.693 
30 sample 3_old 36.15 4.597 9.003 8.925 4.675 
31 sample 4_old 35.4 3.904 9.696 8.596 5.004 
32 sample 5_old 32.2 3.665 9.935 8.468 5.132 
33 sample 6_old 30.15 3.107 10.493 8.152 5.448 
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6.4.2.3. Second Generation Volumes Estimation: 
 
Table 6.6 shows the results related to the volumes estimation depending upon Xitron 
second generation. As stated previously the difference from generation to another will be 
in estimating the volumes at high frequencies not at low frequencies. 
 
Table 6.6: Xitron Second Generation Volumes Estimation . 
Sample# Sample HCT Mean* VICWLF VECWLF VICWHF VECWHF 
1 sample00 46.25 8.010 5.590 7.394 6.206 
2 sample05 43.25 7.256 6.344 7.273 6.327 
3 sample066 43.25 7.429 6.171 7.155 6.445 
4 sample06 43.45 7.110 6.490 7.418 6.182 
5 sample07 46.55 7.110 6.490 7.301 6.299 
6 sample08 37.35 6.220 7.380 6.745 6.855 
7 sample09 45 7.087 6.513 7.820 5.780 
8 sample10 42 6.863 6.737 7.137 6.463 
9 sample11 44.15 7.007 6.593 6.948 6.652 
10 sample12 47.95 7.098 6.502 7.189 6.411 
11 sample13 33 5.395 8.205 5.119 8.481 
12 sample14 41 6.775 6.825 6.907 6.693 
13 sample15 38.75 6.109 7.491 6.626 6.974 
14 sample16 58 8.646 4.954 8.698 4.902 
15 sample17 38 6.496 7.104 6.624 6.976 
16 sample18 47.5 7.656 5.944 7.465 6.135 
17 sample19 38.5 6.342 7.258 6.303 7.297 
18 sample20 51 8.034 5.566 7.818 5.782 
19 sample21 39.25 6.457 7.143 6.574 7.026 
20 sample22 57.75 8.653 4.947 8.804 4.796 
21 sample23 31.8 6.278 7.322 5.545 8.055 
22 sample24 35.35 6.396 7.204 5.399 8.201 
23 sample25 41.25 6.869 6.731 5.875 7.725 
24 sample26 41.15 6.952 6.648 6.103 7.497 
25 sample27 39.3 6.690 6.910 5.800 7.800 
26 sample28 24.95 4.896 8.704 3.580 10.020 
27 sample4e 45.5 7.256 6.344 7.273 6.327 
28 sample 1_old 41.45 5.740 7.860 7.444 6.156 
29 sample 2_old 38.5 5.242 8.358 6.863 6.737 
30 sample 3_old 36.15 4.597 9.003 6.887 6.713 
31 sample 4_old 35.4 3.904 9.696 6.439 7.161 
32 sample 5_old 32.2 3.665 9.935 6.267 7.333 
33 sample 6_old 30.15 3.107 10.493 5.841 7.759 
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6.4.2.4. Developed Surkhi Estimator Volumes Estimation: 
 
Table 6.7 shows the results related to the volumes estimation depending upon the 
developed Surkhi Estimator. 
 
Table 6.7: Developed Surkhi Estimator Volumes Estimation . 
Sample# Sample HCT Mean* VICWLF VECWLF VICWHF VECWHF 
1 sample00 46.25 8.010 5.590 6.597 7.003 
2 sample05 43.25 7.256 6.344 6.473 7.127 
3 sample066 43.25 7.429 6.171 6.351 7.249 
4 sample06 43.45 7.110 6.490 6.622 6.978 
5 sample07 46.55 7.110 6.490 6.501 7.099 
6 sample08 37.35 6.220 7.380 5.935 7.665 
7 sample09 45 7.087 6.513 7.039 6.561 
8 sample10 42 6.863 6.737 6.334 7.266 
9 sample11 44.15 7.007 6.593 6.140 7.460 
10 sample12 47.95 7.098 6.502 6.387 7.213 
11 sample13 33 5.395 8.205 4.325 9.275 
12 sample14 41 6.775 6.825 6.099 7.501 
13 sample15 38.75 6.109 7.491 5.814 7.786 
14 sample16 58 8.646 4.954 7.966 5.634 
15 sample17 38 6.496 7.104 5.812 7.788 
16 sample18 47.5 7.656 5.944 6.670 6.930 
17 sample19 38.5 6.342 7.258 5.489 8.111 
18 sample20 51 8.034 5.566 7.037 6.563 
19 sample21 39.25 6.457 7.143 5.761 7.839 
20 sample22 57.75 8.653 4.947 8.079 5.521 
21 sample23 31.8 6.278 7.322 4.739 8.861 
22 sample24 35.35 6.396 7.204 4.597 9.003 
23 sample25 41.25 6.869 6.731 5.064 8.536 
24 sample26 41.15 6.952 6.648 5.290 8.310 
25 sample27 39.3 6.690 6.910 4.990 8.610 
26 sample28 24.95 4.896 8.704 2.865 10.735 
27 sample4e 45.5 7.256 6.344 6.473 7.127 
28 sample 1_old 41.45 5.740 7.860 6.649 6.951 
29 sample 2_old 38.5 5.242 8.358 6.054 7.546 
30 sample 3_old 36.15 4.597 9.003 6.078 7.522 
31 sample 4_old 35.4 3.904 9.696 5.626 7.974 
32 sample 5_old 32.2 3.665 9.935 5.453 8.147 
33 sample 6_old 30.15 3.107 10.493 5.030 8.570 
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6.4.2.5. Comparison between Used and Developed Volumes Estimators: 
 
As you can notice from the tables that present the volumes estimation, the developed 
Surkhi Estimator gives the best results for volumes estimation. If sample15 is taken as an 
example and the rational value (VICW/VECW) is found, the following figure will be 
obtained.  
 
Figure 6.8: Comparison between Used and Developed Estimator in determining volumes for sample15. 
 
Figure 6.8 gives the volumes estimation as a rational relation between Intracellular and 
Extracellular volume content. Referring to table 6.4 which includes the theoretical 
volumes, the value of the rational quantity (VICW/VECW) for sample15 is (5.27/8.33=0.633) 
and the Surkhi estimator gives the best estimation for that value . As a result the developed 
Surkhi estimator gives the best estimation for Intracellular and Extracellular volume 
content. 
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6.4.3. Cole-Cole Parameters 
A common way to describe the behavior of tissue impedance as a function of frequency is 
to fit the measured data to a mathematical model. Cole-Cole Model is developed by Cole 
and Cole [1941] and is the most common used model as described in chapter three and 
Eq(3.6). Table 6.8 shows the obtained results for Cole-Cole parameters according to the 
Cole-Cole model. 
Table 6.8: Cole-Cole Parameters . 
Sample# Sample Ro (Ohm) Rinf (Ohm) Alfa fc (KHz) 
1 sample00 99.113 55.927 0.138 491.000 
2 sample05 78.647 46.686 0.134 625.000 
3 sample066 75.786 42.671 0.166 737.000 
4 sample06 80.307 45.665 0.145 728.000 
5 sample07 76.827 43.060 0.164 721.000 
6 sample08 62.924 38.269 0.176 954.000 
7 sample09 75.244 36.875 0.165 877.000 
8 sample10 72.127 41.967 0.149 624.000 
9 sample11 74.610 44.574 0.143 509.000 
10 sample12 76.086 44.726 0.135 527.000 
11 sample13 54.153 37.619 0.119 1342.000 
12 sample14 71.505 46.003 0.093 802.000 
13 sample15 61.790 39.693 0.136 780.000 
14 sample16 115.139 55.365 0.067 515.000 
15 sample17 67.264 40.369 0.146 597.000 
16 sample18 87.913 49.463 0.112 519.000 
17 sample19 64.979 43.145 0.090 478.000 
18 sample20 96.770 50.800 0.112 518.000 
19 sample21 66.503 45.164 0.081 620.000 
20 sample22 115.257 52.642 0.096 506.000 
21 sample23 62.998 44.340 0.143 676.000 
22 sample24 64.597 47.137 0.079 712.000 
23 sample25 72.581 47.149 0.102 800.000 
24 sample26 74.066 49.758 0.075 650.000 
25 sample27 70.147 48.132 0.084 631.000 
26 sample28 49.519 42.157 0.041 490.000 
27 sample4e 78.647 46.686 0.134 625.000 
28 sample 1_old 58.797 34.195 0.167 673.000 
29 sample 2_old 52.672 27.650 0.259 1220.000 
30 sample 3_old 47.439 28.672 0.252 1160.000 
31 sample 4_old 41.976 29.162 0.238 928.000 
32 sample 5_old 40.449 28.319 0.266 1000.000 
33 sample 6_old 37.574 24.828 0.350 1280.000 
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Chapter Seven: Discussion of Results 
 
 
This chapter discusses and analyzes the obtained results that are presented in chapter five. 
First the results related to Haematocrit values are discussed and analyzed, then the results 
related to the volumes estimation are also be analyzed and the inaccuracies of the 
estimators will be indicated.  
 
7.1 HCT Error (Absolute and Relative Error) 
 
This section introduces the errors between the actual values of the Haematocrit and the 
estimated values based upon Xitron first, second generations and the developed Surkhi 
estimator. 
  
7.1.1. Difference between HCT Hospital & University: 
 
 
HCT Hospital is measured at HGH at the moment of collecting the blood sample. After 
collecting the blood sample, the sample is taken to the university for experimental works. 
The travel time plus the time of experiments are about three hours. In order to validate that 
the blood sample isn‟t damaged or the HCT didn‟t change significantly during this time 
 77 
 
due to clotting, the HCT is measured again after taking bioimpedance measurements in the 
medical school at Al-Quds University. 
 
The average of the differences between Hospital HCT values and University HCT values is 
found, the difference is very small and with an average of 2.124 as shown in table 7.1. 
 
Table 7.1: Difference between HCT Hospital & University . 
Sample# Sample Hospital HCT University HCT Difference 
1 sample00 46.5 46 0.5 
2 sample05 43.3 42.5 0.8 
3 sample066 43 43.5 -0.5 
4 sample06 43.4 43.5 -0.1 
5 sample07 47.6 45.5 2.1 
6 sample08 40.7 34 6.7 
7 sample09 47 43 4 
8 sample10 42 42 0 
9 sample11 45.8 42.5 3.3 
10 sample12 52.9 43 9.9 
11 sample13 34 32 2 
12 sample14 42 40 2 
13 sample15 40 37.5 2.5 
14 sample16 58 58 0 
15 sample17 39 37 2 
16 sample18 48 47 1 
17 sample19 39 38 1 
18 sample20 51 51 0 
19 sample21 40 38.5 1.5 
20 sample22 58 57.5 0.5 
21 sample23 31.6 32 -0.4 
22 sample24 35.7 35 0.7 
23 sample25 41.5 41 0.5 
24 sample26 42.3 40 2.3 
25 sample27 38.6 40 -1.4 
26 sample28 24.9 25 -0.1 
27 sample4e 46 45 1 
28 sample 1_old 43 39.9 3.1 
29 sample 2_old 40 37 3 
30 sample 3_old 38 34.3 3.7 
31 sample 4_old 39 31.8 7.2 
32 sample 5_old 35 29.4 5.6 
33 sample 6_old 33 27.3 5.7 
Difference Average 2.124 
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The following figure shows the differences between HCT Hospital and University: 
 
 
 
Figure 7.1: Difference between HCT Hospital and HCT University. 
 
As shown in figure 7.1 there is no significant difference between the two measured 
values of HCT. 
 
 
 
7.1.2. Accuracies of Estimators- HCT Error analysis  (Absolute & Relative Error): 
 
This section indicates the inaccuracies of the used and developed estimators by 
comparing the actual values of HCT measured in hospital and university with the 
estimated values using the estimators.  
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7.1.2.1. HCT absolute & relative error related to Hospital HCT: 
 
Table 7.2 shows HCT absolute & relative error related to Hospital HCT by taking the 
mean values for all 33 samples. 
Table 7.2: HCT absolute & relative error related to Hospital HCT . 
 1
st
 Generation 2
nd
 Generation Surkhi Estimator 
HCT 
Hospital  
First 
Gen. 
HCT  
Absolute 
Error  
Relative 
Error 
%  
Second 
Gen. 
HCT  
Absolute 
Error  
Relative 
Error 
(%)  
Surkhi 
HCT  
Absolute  
Error  
Relative 
Error 
(%)  
42.115 64.368 22.253 55.022 49.457 7.017 18.228 43.748 3.094 3.919 
 
 
7.1.2.2. HCT absolute & relative error related to University HCT: 
 
Table 7.3 shows HCT absolute & relative error related to University HCT by taking the 
mean values for all 33 samples. 
Table 7.3: HCT absolute & relative error related to University HCT . 
 1
st
 Generation 2
nd
 Generation Surkhi Estimator 
HCT 
University  
First 
Gen. 
HCT  
Absolute 
Error  
Relative 
Error 
(%)  
Second 
Gen. 
HCT  
Absolute 
Error  
Relative 
Error 
(%)  
Surkhi 
HCT  
Absolute  
Error  
Relative 
Error 
(%)  
39.991 64.368 24.377 64.264 49.457 9.108 25.313 43.748 4.576 10.139 
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7.1.2.3. HCT absolute & relative error related to the mean of Hospital and University 
HCT: 
 
Table 7.4 shows HCT absolute & relative error related to the mean value of Hospital 
HCT and University HCT by taking the mean values for all 33 samples. 
Table 7.4: HCT absolute & relative error related to mean of Hospital & University HCT . 
 1
st
 Generation 2
nd
 Generation Surkhi Estimator 
HCT 
Mean* 
First 
Gen. 
HCT 
Absolute 
Error 
Relative 
Error 
(%) 
Second 
Gen. 
HCT 
Absolute 
Error 
Relative 
Error 
(%) 
Surkhi 
HCT 
Absolute 
Error 
Relative 
Error 
(%) 
41.064 64.368 23.304 59.288 49.457 8.543 21.502 43.748 3.684 6.792 
 
 
 
7.2 Volumes Error (Absolute & Relative Error)  
 
7.2.1. Low Frequency Extracellular Volume (Absolute & Relative Error): 
 
Table 7.5 shows the low frequency extracellular volume absolute and relative error (Xitron 
First, Second generation and Surkhi Estimator) by taking the mean values for all 33 
samples. 
Table 7.5: Low frequency extracellular volume absolute and relative error . 
HCT Mean* 
Theoretical V
ECW
 
(cm
3
) 
Estimated V
ECWLF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 8.015 7.135 1.058 11.340 
 
 
7.2.2. Low Frequency Intracellular Volume (Absolute & Relative Error): 
 
Table 7.6 shows the low frequency intracellular volume absolute and relative error (Xitron 
first, second generations and Surkhi Estimator) by taking the mean values for all 33 
samples. 
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Table 7.6: Low frequency intracellular volume absolute and relative error . 
HCT Mean* 
Theoretical V
ICW
 
(cm
3
) 
Estimated V
ICWLF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 5.585 6.465 1.058 83.215 
 
 
7.2.3. High Frequency Extracellular Volume Absolute & Relative Error Related to 
Xitron First Generation: 
Table 7.7 shows the High Frequency Extracellular Volume Absolute & Relative Error 
Related to Xitron First Generation by taking the mean values for all 33 samples. 
Table 7.7: High Frequency Extracellular Volume Absolute & Relative Error Related to Xitron 
First Generation . 
HCT Mean* 
Theoretical V
ECW
 
(cm
3
) 
Estimated V
ECWHF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 8.015 4.784 3.231 40.31 
 
 
7.2.4. High Frequency Intracellular Volume Absolute & Relative Error Related to 
Xitron First Generation: 
Table 7.8 shows the High Frequency Intracellular Volume Absolute & Relative Error 
Related to Xitron First Generation by taking the mean values for all 33 samples. 
 
Table 7.8: High Frequency Intracellular Volume Absolute & Relative Error Related to Xitron First 
Generation . 
HCT Mean* 
Theoretical V
ICW
 
(cm
3
) 
Estimated V
ICWHF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 5.585 8.816 3.231 57.85 
 
 
7.2.5. High Frequency Extracellular Volume Absolute & Relative Error Related to 
Xitron Second Generation: 
 
Table 7.9 shows the High Frequency Extracellular Volume Absolute & Relative Error 
Related to Xitron Second Generation by taking the mean values for all 33 samples. 
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Table 7.9: High Frequency Extracellular Volume Absolute & Relative Error Related to Xitron 
Second Generation . 
HCT Mean* 
Theoretical V
ECW
 
(cm
3
) 
Estimated V
ECWHF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 8.015 6.854 1.161 14.49 
 
 
7.2.6. High Frequency Intracellular Volume Absolute & Relative Error Related to 
Xitron Second Generation: 
 
Table 7.10 shows the High Frequency Intracellular Volume Absolute & Relative Error 
Related to Xitron Second Generation by taking the mean values for all 33 samples. 
Table 7.10: High Frequency Intracellular Volume Absolute & Relative Error Related to Xitron 
Second Generation . 
HCT Mean* 
Theoretical V
ICW
 
(cm
3
) 
Estimated V
ICWHF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 5.585 6.746 1.161 20.79 
 
 
7.2.7. High Frequency Extracellular Volume Absolute & Relative Error Related to 
Surkhi Estimator: 
Table 7.11 shows the High Frequency Extracellular Volume Absolute & Relative Error 
Related to Surkhi Estimator by taking the mean values for all 33 samples. 
Table 7.11: High Frequency Extracellular Volume Absolute & Relative Error Related to Surkhi 
Estimator . 
HCT Mean* 
Theoretical V
ECW
 
(cm
3
) 
Estimated V
ECWHF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 8.015 7.650 0.365 4.55 
 
 
7.2.8. High Frequency Intracellular Volume Absolute & Relative Error Related to 
Surkhi Estimator: 
Table 7.12 shows the High Frequency Intracellular Volume Absolute & Relative Error 
Related to Surkhi Estimator by taking the mean values for all 33 samples. 
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Table 7.12: High Frequency Intracellular Volume Absolute & Relative Error Related to Surkhi 
Estimator . 
HCT Mean* 
Theoretical V
ICW
 
(cm
3
) 
Estimated V
ICWHF
 
(cm
3
) 
Absolute Error 
(cm
3
) 
Relative Error 
(%) 
41.064 5.585 5.950 0.365 6.54 
 
 
7.2.9. A Summary of Volumes Absolute and Relative Errors: 
 
Table 7.13 shows a summary of the volumes absolute and relative error related to the 
used estimators. 
Table 7.13-A: Volumes Absolute & Relative Errors Related to Xitron First Generation . 
Theoretical 
V
ICW
(cm
3
) 
Measured 
V
ICWLF
(cm
3
) 
1st Gen 
 V
ICWHF
 
(cm
3
) 
Absolute 
Error (cm
3
) 
Relative 
Error (%) 
5.585 6.465 8.816 3.231 57.85 
 
 
Table 7.13-B: Volumes Absolute & Relative Errors Related to Xitron Second Generation . 
Theoretical 
V
ICW
(cm
3
) 
Measured 
V
ICWLF
(cm
3
) 
2
nd
 Gen  
V
ICWHF
 
(cm
3
) 
Absolute 
Error (cm
3
) 
Relative 
Error (%) 
5.585 6.465 6.746 1.161 20.79 
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Table 7.13-C: Volumes Absolute & Relative Errors Related to Surkhi Estimator . 
Theoretical 
V
ICW
(cm
3
) 
Measured 
V
ICWLF
(cm
3
) 
Surkhi  
V
ICW HF 
(cm
3
) 
Absolute 
Error (cm
3
) 
Relative Error 
(%) 
5.585 6.465 5.950 0.365 6.54 
 
 
As can be noticed from table 7.13, Surkhi Estimator gives the smallest absolute and 
relative errors compared to Xitron first and second generations. Therefore Surkhi 
Estimator has the nearest volume values from the theoretical ones. 
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Chapter Eight: Conclusions, Limitations and Future Work 
 
 
8.1 Conclusions 
 
The following points can be noticed from the tables listed in chapter seven as 
conclusion: 
 
• There is no great difference between HCT Hospital and University readings 
(∆HCT= 2.124); so the blood samples are carefully protected. 
 
• Surkhi Estimator gives us the best results for HCT values with relative error 
between 3% and 10%. 
 
• Xitron First Generation has the highest error in determining HCT values with 
relative error of 55%. 
 
• Low Frequency Volumes Estimation are the same for all generations. 
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• High Frequency Volumes Estimation differ from generation to other. 
 
• Xitron First & Second Genertaion Volumes Estimation are overestimated compared 
to the intracellular volumes with relative error of 58% for first generation and 21% 
for second generation. 
 
• Xitron First Generation is overestimated than Xitron Second Generation. 
 
• Surkhi Estimator gives us the best results for volumes estimation with relative error 
between 4% and 6.8%. 
 
• The characteristic frequency of the samples occurs between 478 KHz and 1342KHz 
(mean=910KHz). This result fits with the results in literature. Ulgen & Sezdi in 
1998 (937 KHz) [16], Gaw in 2010 (700 KHz to 1 MHz) [15]. 
 
In this research, electrical impedance spectroscopy of blood is performed at six frequencies 
which are: 10, 20, 50, 100, 220 and 500KHz using the two probe method in order to 
determine the Cole-Cole parameters, namely the resistances R∞ and R0, the characteristic 
frequency (fc) and the parameter α (0 < α ≤ 1). Only those six frequencies are used in 
fitting the Cole circle, where the effects of electrode polarization are negligible. Fitting 
needs three readings but six readings are taken then the rest of readings are found using 
Cole-Cole model. As human blood tissue is used in this research the used frequency can‟t 
be below 1KHz in order not to conflict with the human body systems such as heart rate for 
an example. From the results you notice that go above 500KHz make the results noisy so 
those six frequencies are chosen to take measurements then fitting using Cole-Cole model 
was used. 
 
All the measurements are done at room temperature (25°C) where as the blood samples are 
well preserved and tested. 
 
It is shown that this is acceptable since the characteristic frequency of samples occurs 
between 478 KHz and 1342KHz depending upon the value of the sample HCT. This result 
matches what is founded by Richelle Leanne Gaw in his thesis in the year 2010 as he 
 87 
 
mentioned that the characteristic frequency (fc) of human blood is in the order of 700 KHz 
to 1 MHz [15]. 
 
The characteristic frequency (fc) gets lower for each anticoagulant as the volume occupied 
by red blood cells become greater implying a larger effective cell membrane capacitance. 
 
In previous results of Dellimore and Gosling (1975) (a  time  constant)  between  40  and  
50  second is reported. Whereas Yamakoshi and Tanaka (1994) reported that the measured 
frequency is 50 KHz [15]. 
 
Bernard Rigaudt, Leila Hamzaouit, Mohamed Ridha Frikhaf, Nicolas Chauveaut and Jean-
Pierre Moruccit (1995) had worked upon many tissues such as Muscle, Liver, Lung and 
Spleen and found that the characteristic frequency (fc) is 27KHz for Muscle, 72 KHz for 
Liver, 140 KHz for Lung and 373 KHz for Spleen.  
 
DeLorenzo (1997) had worked with Total Body Potassium (TBK) and diluted samples for 
men and women and his study reported the following results: TBK(Men: 57.02±8.39KHz, 
Women: 80.14±17.22KHz, Combined: 60.19±12.83). Dilution, Men: 61.96±5.95KHz [10]. 
 
The characteristic frequency of stationary blood is reported to be 937 KHz by Ulgen & 
Sezdi (1998) [16]. 
 
Grimnes & Martinsen 2000 stated in their study that the characteristic frequency increase 
after sedimentation begins[15]. 
 
In previous results of Ward and Stroud 2001, the characteristic frequency is reported as 50 
KHz.  
 
Richelle Leanne Gaw (2010) reported that the characteristic frequency of bovine blood in 
the order of 1500 KHz and for stationary blood as 1948 KHz. Also he had investigated the 
relationship between the characteristic frequency and sedimentation and reported that 15 
minutes after sedimentation begins, the characteristic frequency of blood is 1.2 MHz. 90 – 
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270 minutes after sedimentation begins, the characteristic frequency increased to 1.5 MHz 
[15]. 
 
Resistivity of blood is complex and is a function of many parameters such as: the shape of 
red blood cells, the volume concentration of red cells (Haematocrit), the type of 
anticoagulant, the temperature and the frequency. 
 
Because each sample has a different Haematocrit values either normalization is necessary 
or else the results should be displayed as a function of Haematocrit (h). 
 
At 100% Haematocrit the extracellular conductivity is zero. 
 
As mentioned before that the value of the parameter α  is between (0 < α ≤ 1) and 
according to the measurements that are done during this work, the value of α is between 
0.041 and 0.349 . 
The value of R0 in this work varies between 37.574 Ohm and 115.257 Ohm depending 
upon the value of the sample HCT. 
 
The value of R∞ in this work varies between 24.828 Ohm and 55.927 Ohm depending upon 
the value of the sample HCT. 
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8.2 Limitations 
 
The blood samples are collected from Hebron Governmental Hospital at Hebron city and 
must be transported from Hebron to Jerusalem without damaging human blood tissue. The 
transportation time of human blood samples from Hebron to Jerusalem and the 
experimental time was very long, so we can‟t work with more than one sample a day to 
make sure the blood samples do not damage. 
 
By using Microtest Impedance Analyzer instrument, raw data are not easily accessible, no 
driver available and it is hard to connect to labview. Local Impedance Analyzer is more 
friendly to be used. 
 
8.3 However its worth to mention?  
 
All this research work including the experimental and lab work, data analysis and 
instrumentation are performed at the labs of engineering school (Material Engineering 
Lab) plus medicine school at Al-Quds University.  
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8.4 Recommendation for Future Work 
 
As shown and concluded from this thesis results, Surkhi Estimator gives the best results for 
determining volumes and Haematocrit values with the small error compared to the 
theoretical values. Therefore I recommend to use this estimator by bioimpedance systems 
producing companies. For an example Surkhi Estimator can be used to monitor babies 
growth or to differentiate between normal and cancerous tissues as cancerous tissues have 
more water content than normal tissues. Add to that Surkhi Estimator can be used in 
designing Haemodialysis machines to monitor the fluid volumes. 
Also I recommend the people who are interested in this subject to complete this work 
depending upon the following points: 
 
 Testing blood samples on a wide range of frequencies and using more than the six 
used frequencies in this work and try to work on a higher range of frequencies. 
 
 Evaluate tissue parameters out of the Bioimpedance measurements such as Normal 
or pathological conditions of the membrane. 
 
 Investigate different blood samples with different medical conditions (different 
HCT values, different health conditions) in correlation with bioimpedance. 
 
 Study the correlations between Cole-Cole parameters and blood  HCT value. 
 
 Investigate animal blood. 
 
 Working on other biological tissue such as spleen, liver and others. 
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Appendix A: The Outgoing Books 
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Appendix B: MATLAB Codes  
 
1. Matlab M-File for Volumes and Haematocrit Estimation 
 
 
F=[10000 20000 50000 100000 220000 500000]; 
  
file=input('Enter file name: ','s'); 
  
dat=load(file); 
  
daat=mean(dat(2:length(dat),:)); 
  
c1=1; 
c2=1; 
L=1; 
  
zd=daat(1,8:13); 
pd=daat(1,26:31); 
  
z=zd'; 
ph=pd'; 
f=F'; 
  
dib=1; 
 % z module 
 % phase 
 % frequencies 
  
r(:,1)=(z(:,1).*cos(ph(:,1)*pi/180));% resistance 
img(:,1)=(z(:,1).*sin(ph(:,1)*pi/180));   % reactance 
  
 [ro,ri,alf,fc,ecm2]=colez(r,img,f,dib); 
  
% Function for Cole-Cole Parameters & Impedancies 
% Outputs: 
% ro=resistence zero 
% ri=resistence infinity  
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% alf=angle alfa 
% fc=central frequency  
% ecm=error quadratice media 
  
% Inputs: 
% r=real part of the impedance vector 
% i= imaginary part of the frequency vector 
% f= frequencies vector 
% dib= 0 for no depression, 1 for depression of the curve module 
 
  
% Calculation of the center y for the radius of the circle frequencies 
% approximation 
img=abs(img); 
 n=length(f); 
for ii=1:4 
    for jj=1:4 
    m(ii,jj)=mean(r.^(ii-1).* img.^(jj-1)); 
    end 
end 
sigmx2=m(3,1)-m(2,1)^2; 
sigmxy=m(2,2)-m(1,2)*m(2,1); 
sigmy2=m(1,3)-m(1,2)^2; 
t1=(-m(4,1)+m(2,1)*m(3,1)-m(2,3)+m(2,1)*m(1,3)); 
t2=(-m(1,4)+m(1,2)*m(1,3)-m(3,2)+m(1,2)*m(3,1)); 
t3=sigmx2*sigmy2-sigmxy^2; 
a=-0.5*(sigmy2*t1-sigmxy*t2)/t3; 
b=-0.5*(sigmx2*t2-sigmxy*t1)/t3; 
% b=-abs(b); 
radius=mean(sqrt((r-a).^2+(img-b).^2)); 
  
% Calculation of  ro,ri,alf 
ro=a+(radius^2-b^2)^0.5; 
ri=a-(radius^2-b^2)^0.5; 
alf=1-(2/pi)*asin((ro-ri)/(2*radius)); 
  
% Calculation of fc 
u=((r.^2-2*ri.*r+img.^2)+(ri^2)).^0.5; 
v=((r.^2-2*ro.*r+img.^2)+(ro^2)).^0.5; 
ww=log10(abs(u./v)); 
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p=log10(2*pi*f); 
h=polyfit(p,ww,1); 
fc=((1/(2*pi))*10^(-h(2)/h(1))); 
  
% Calculation of the error quadratic media 
  
ye=(-abs(b)+(radius^2.-(r-a).^2).^0.5); 
er=(abs(ye)-abs(img))./radius; 
ecm=(((sum(er.^2))^0.5)/n)*100; 
er2=(abs(ye)-abs(img))./abs(img); 
ecm2=(((sum(er2.^2))^0.5)/n)*100; 
ecm3=(sum(abs(er)))*100/n; 
  
if dib==1, 
     
    axis(axis);  
    dd=ro/ri; 
    dd=dd/150; 
    xx=[ri:dd:ro]; 
    c=1-(sin((pi/2)*(1-alf)))^2; 
    a=(ro+ri)/2; 
    b=((ro-ri)/2)*(c/(1-c))^0.5; 
    radius=(((ro-a)^2)+b^2)^0.5; 
    yy=(-abs(b)+(radius^2.-(xx-a).^2).^0.5); 
    figure(1) 
    plot(xx,abs(yy),'r'); 
    drawnow; 
    axis image 
    hold on; 
    %plot(r,img,'o') 
end; 
%ro 
%ri  
%alf   
%fc  
%ecm2 
  
%TTV =(0.25/pi)*(c2*c2-0.25*(c2-c1)^2)  
%K=L^2*47*(TTV)^-0.5; 
%ECW_cm3=K*(ro)^(-2/3) 
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Recavg=ro; 
Roavg=ro; 
Rinfavg=ri; 
Ricavg=(ri*ro)/(ro-ri); 
  
ff=[100:100:1000000]; 
dr=ro-ri; 
 zf=dr./(1+(i*ff./fc).^(1-alf))+ri; 
  
 figure(2) 
semilogx(f,z,'-ro') 
title ('Z mod') 
  
semilogx(ff,abs(zf)) 
  
figure(3) 
  
 semilogx(f,ph,'ro') 
  
title('Phase') 
  
semilogx(ff, 57.2957795*phase(zf)) 
  
AAAavg=[Roavg,Rinfavg,Recavg,Ricavg] 
  
  
  
clear ro ri daat 
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% 'Select the time of intrest between  ',[ 0 length(dat) ] 
  
%j=input (' Time: ') 
  
daat=dat(2:length(dat),:); 
  
%clean artifacts from data  
for j=1:37 
for i=1:length(daat) 
    if (daat(i,j))> 1.1*(median(daat(:,j))) 
     daat(i,j)= median(daat(:,j)); 
    
    end 
end 
end 
  
for j=1:37 
for i=1:length(daat) 
    if (daat(i,j))< 0.9*(median(daat(:,j))) 
     daat(i,j)= median(daat(:,j)); 
    
    end 
end 
end 
     
% step 2: plot all data  
  
for aaa=1:length(daat) 
   
c1=1; 
c2=1; 
L=1; 
  
zd=daat(aaa,8:13); 
pd=daat(aaa,26:31); 
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z=zd'; 
ph=pd'; 
f=F'; 
dib=1; 
 % z module 
 % phase 
 % frequencies 
  
r(:,1)=(z(:,1).*cos(ph(:,1)*pi/180));% resistance 
img(:,1)=(z(:,1).*sin(ph(:,1)*pi/180));   % reactance 
  
 
 [ro,ri,alf,fc,ecm2]=colez(r,img,f,dib); 
  
% Function for Cole-Cole Parameters & Impedancies 
% Outputs: 
% ro=resistence zero 
% ri=resistence infinity  
% alf=angle alfa 
% fc=central frequency  
% ecm=error quadratice media 
  
% Inputs: 
% r=real part of the impedance vector 
% i= imaginary part of the frequency vector 
% f= frequencies vector 
% dib= 0 for no depression, 1 for depression of the curve module 
  
 
% Calculation of the center y for the radius of the circle frequencies 
% approximation 
img=abs(img); 
 n=length(f); 
for ii=1:4 
    for jj=1:4 
    m(ii,jj)=mean(r.^(ii-1).* img.^(jj-1)); 
    end 
end 
sigmx2=m(3,1)-m(2,1)^2; 
sigmxy=m(2,2)-m(1,2)*m(2,1); 
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sigmy2=m(1,3)-m(1,2)^2; 
t1=(-m(4,1)+m(2,1)*m(3,1)-m(2,3)+m(2,1)*m(1,3)); 
t2=(-m(1,4)+m(1,2)*m(1,3)-m(3,2)+m(1,2)*m(3,1)); 
t3=sigmx2*sigmy2-sigmxy^2; 
a=-0.5*(sigmy2*t1-sigmxy*t2)/t3; 
b=-0.5*(sigmx2*t2-sigmxy*t1)/t3; 
% b=-abs(b); 
radius=mean(sqrt((r-a).^2+(img-b).^2)); 
  
% Calculation of ro,ri,alf 
ro=a+(radius^2-b^2)^0.5; 
ri=a-(radius^2-b^2)^0.5; 
alf=1-(2/pi)*asin((ro-ri)/(2*radius)); 
  
% Calculation of fc 
u=((r.^2-2*ri.*r+img.^2)+(ri^2)).^0.5; 
v=((r.^2-2*ro.*r+img.^2)+(ro^2)).^0.5; 
ww=log10(abs(u./v)); 
p=log10(2*pi*f); 
h=polyfit(p,ww,1); 
fc=((1/(2*pi))*10^(-h(2)/h(1))); 
  
% Calculation of the error quadratic media 
  
ye=(-abs(b)+(radius^2.-(r-a).^2).^0.5); 
er=(abs(ye)-abs(img))./radius; 
ecm=(((sum(er.^2))^0.5)/n)*100; 
er2=(abs(ye)-abs(img))./abs(img); 
ecm2=(((sum(er2.^2))^0.5)/n)*100; 
ecm3=(sum(abs(er)))*100/n; 
  
if dib==1, 
     
    axis(axis);  
    dd=ro/ri; 
    dd=dd/150; 
    xx=[ri:dd:ro]; 
    c=1-(sin((pi/2)*(1-alf)))^2; 
    a=(ro+ri)/2; 
    b=((ro-ri)/2)*(c/(1-c))^0.5; 
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    radius=(((ro-a)^2)+b^2)^0.5; 
    yy=(-abs(b)+(radius^2.-(xx-a).^2).^0.5); 
    figure(4) 
    plot(xx,abs(yy),'r'); 
    drawnow; 
    axis image 
    hold on; 
    %plot(r,img,'o') 
end; 
%ro 
%ri  
%alf   
%fc  
%ecm2 
  
%TTV =(0.25/pi)*(c2*c2-0.25*(c2-c1)^2)  
%K=L^2*47*(TTV)^-0.5; 
%ECW_cm3=K*(ro)^(-2/3) 
  
  
Rec=ro; 
Ro=ro; 
Rinf=ri; 
Ric=(ri*ro)/(ro-ri); 
  
  
AAA(aaa,:)=[Ro,Rinf,Rec,Ric]; 
end 
  
  
%clear i 
%for j=1:4 
%for i=1:length(AAA) 
 %   if (AAA(i,j))> 1.1*(median(AAA(:,j))) 
  %     AAA(i,j)= median(AAA(:,j)); 
    
   % end 
%end 
%end 
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VicVecOmar=1.19*(AAA(:,1)./AAA(:,2))-1.18; 
VicVecPere=2.22*(AAA(:,1)./AAA(:,2))-1.8; 
VicVecMath=1.47*(AAA(:,1)./AAA(:,2))-1.43; 
  
HTCOmar=1./(1+(1./VicVecOmar)); 
HTCPere=1./(1+(1./VicVecPere)); 
HTCMath=1./(1+(1./VicVecMath)); 
HTCOmar=abs(HTCOmar); 
HTCPere=abs(HTCPere); 
HTCMath=abs(HTCMath); 
  
%  Standard Deviation 
HTCPere_sd=std(HTCPere); 
HTCMath_sd=std(HTCMath) 
HTCOmar_sd=std(HTCOmar); 
  
  
  
figure(6) 
plot(VicVecOmar,'g') 
hold on  
plot(VicVecPere,'r') 
plot(VicVecMath,'b') 
xlabel('time') 
ylabel('Vic/Vec') 
legend('(Omar )','(Pere)','(Matthie)',1) 
grid on 
  
figure(7) 
plot(HTCOmar,'g') 
hold on  
plot(HTCPere,'r') 
plot(HTCMath,'b') 
xlabel('time') 
ylabel('HTC') 
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legend('(Omar )','(Pere)','(Matthie)',1) 
grid on 
  
  
% omar estimators based on LF and HF 
% LF 
resplasma= 70.53; 
  
VECLF=((resplasma*2.21^2*13.6^0.5)/AAAavg(1))^(2/3); 
VICLF=13.6-VECLF; 
HTCLF=VICLF/13.6; 
  
%HF 
VicVecOmar=1.19*(AAAavg(1)/AAAavg(2))-1.18; 
VicVecPere=2.22*(AAAavg(1)/AAAavg(2))-1.8; 
VicVecMath=1.47*(AAAavg(1)/AAAavg(2))-1.43; 
  
HTCHFomar=1/(1+(1/VicVecOmar)); 
HTCHFpere=1/(1+(1/VicVecPere)); 
HTCHFmath=1/(1+(1/VicVecMath)); 
  
  
VICHFomar=HTCHFomar*13.6; 
VECHFomar=13.6-VICHFomar; 
  
VICHFpere=HTCHFpere*13.6; 
VECHFpere=13.6-VICHFpere; 
  
VICHFmath=HTCHFmath*13.6; 
VECHFmath=13.6-VICHFmath; 
  
  
  
Aresult=[mean(HTCOmar) mean(HTCPere) mean(HTCMath)] 
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%......................................................... 
% plot using charts  
figure (10) 
  
subplot(2,2,1) 
  
x = [VECLF VICLF ]; 
explode = [0 1 ]; 
h=pie(x,explode); 
colormap JET 
  
  
textObjs = findobj(h,'Type','text'); 
oldStr = get(textObjs,{'String'}); 
val = get(textObjs,{'Extent'}); 
oldExt = cat(1,val{:}); 
  
Names = {'ECW: ';'ICW: '}; 
newStr = strcat(Names,oldStr); 
set(textObjs,{'String'},newStr,'FontSize',8) 
  
  
val1 = get(textObjs, {'Extent'}); 
newExt = cat(1, val1{:}); 
offset = sign(oldExt(:,1)).*(newExt(:,3)-oldExt(:,3))/2; 
pos = get(textObjs, {'Position'}); 
textPos =  cat(1, pos{:}); 
textPos(:,1) = textPos(:,1)+offset; 
set(textObjs,{'Position'},num2cell(textPos,[3,2])) 
  
s='LF Estimator  HTC= '; 
 st=[s num2str(HTCLF)] 
title(st,'FontSize',10) 
  
%*********************************************** 
subplot(2,2,2) 
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x = [VECHFomar VICHFomar ]; 
explode = [0 1 ]; 
h=pie(x,explode); 
colormap JET 
  
  
textObjs = findobj(h,'Type','text'); 
oldStr = get(textObjs,{'String'}); 
val = get(textObjs,{'Extent'}); 
oldExt = cat(1,val{:}); 
  
Names = {'ECW: ';'ICW: '}; 
newStr = strcat(Names,oldStr); 
set(textObjs,{'String'},newStr,'FontSize',8) 
  
  
  
val1 = get(textObjs, {'Extent'}); 
newExt = cat(1, val1{:}); 
offset = sign(oldExt(:,1)).*(newExt(:,3)-oldExt(:,3))/2; 
pos = get(textObjs, {'Position'}); 
textPos =  cat(1, pos{:}); 
textPos(:,1) = textPos(:,1)+offset; 
set(textObjs,{'Position'},num2cell(textPos,[3,2])) 
  
s='Omar HF Estimator  HTC= '; 
 st=[s num2str(HTCHFomar)] 
title(st,'FontSize',10) 
  
%***************************** 
subplot(2,2,3) 
  
x = [VECHFpere VICHFpere ]; 
explode = [0 1 ]; 
h=pie(x,explode); 
colormap JET 
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textObjs = findobj(h,'Type','text'); 
oldStr = get(textObjs,{'String'}); 
val = get(textObjs,{'Extent'}); 
oldExt = cat(1,val{:}); 
  
Names = {'ECW: ';'ICW: '}; 
newStr = strcat(Names,oldStr); 
set(textObjs,{'String'},newStr,'FontSize',8) 
  
  
val1 = get(textObjs, {'Extent'}); 
newExt = cat(1, val1{:}); 
offset = sign(oldExt(:,1)).*(newExt(:,3)-oldExt(:,3))/2; 
pos = get(textObjs, {'Position'}); 
textPos =  cat(1, pos{:}); 
textPos(:,1) = textPos(:,1)+offset; 
set(textObjs,{'Position'},num2cell(textPos,[3,2])) 
  
s='Pere HF Estimator  HTC= '; 
 st=[s num2str(HTCHFpere)] 
title(st,'FontSize',10) 
%*********************************************** 
subplot(2,2,4) 
  
x = [VECHFmath VICHFmath ]; 
explode = [0 1 ]; 
h=pie(x,explode); 
colormap JET 
  
  
textObjs = findobj(h,'Type','text'); 
oldStr = get(textObjs,{'String'}); 
val = get(textObjs,{'Extent'}); 
oldExt = cat(1,val{:}); 
  
Names = {'ECW: ';'ICW: '}; 
newStr = strcat(Names,oldStr); 
set(textObjs,{'String'},newStr,'FontSize',8) 
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val1 = get(textObjs, {'Extent'}); 
newExt = cat(1, val1{:}); 
offset = sign(oldExt(:,1)).*(newExt(:,3)-oldExt(:,3))/2; 
pos = get(textObjs, {'Position'}); 
textPos =  cat(1, pos{:}); 
textPos(:,1) = textPos(:,1)+offset; 
set(textObjs,{'Position'},num2cell(textPos,[3,2])) 
  
s='Matthie HF Estimator  HTC= '; 
 st=[s num2str(HTCHFmath)] 
title(st,'FontSize',10) 
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2. Matlab M-file for Finding Cole-Cole Parameters 
 
  
% This program finds the Cole-Cole parameters for the Z file. 
% input file: sample***.CAL 
% output : Cole data in the data table called Cole in the order of 
%cole=[roo rii fcc alff]; 
  
F=[10000 20000 50000 100000 220000 500000]; 
  
file=input('Enter file name: ','s'); 
  
dat=load(file); 
  
 
daat=(dat(2:length(dat),:)); 
  
for hh=1:length(daat) 
  
zd=daat(hh,8:13); 
pd=daat(hh,26:31); 
  
z=zd'; 
ph=pd'; 
f=F'; 
 
  
dib=1; 
  
r(:,1)=(z(:,1).*cos(ph(:,1)*pi/180));% resistance 
img(:,1)=(z(:,1).*sin(ph(:,1)*pi/180));   % reactance 
  
  
 [ro,ri,alf,fc,ecm2]=colez(r,img,f,dib); 
  
  
% Function for Cole-Cole Parameters & Impedancies 
% Outputs: 
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% ro=resistence zero 
% ri=resistence infinity  
% alf=angle alfa 
% fc=central frequency  
% ecm=error quadratice media 
  
% Inputs: 
% r=real part of the impedance vector 
% i= imaginary part of the frequency vector 
% f= frequencies vector 
% dib= 0 for no depression, 1 for depression of the curve module 
 
  
% Calculation of the center y for the radius of the circle frequencies 
% approximation 
img=abs(img); 
 n=length(f); 
for ii=1:4 
    for jj=1:4 
    m(ii,jj)=mean(r.^(ii-1).* img.^(jj-1)); 
    end 
end 
sigmx2=m(3,1)-m(2,1)^2; 
sigmxy=m(2,2)-m(1,2)*m(2,1); 
sigmy2=m(1,3)-m(1,2)^2; 
t1=(-m(4,1)+m(2,1)*m(3,1)-m(2,3)+m(2,1)*m(1,3)); 
t2=(-m(1,4)+m(1,2)*m(1,3)-m(3,2)+m(1,2)*m(3,1)); 
t3=sigmx2*sigmy2-sigmxy^2; 
a=-0.5*(sigmy2*t1-sigmxy*t2)/t3; 
b=-0.5*(sigmx2*t2-sigmxy*t1)/t3; 
% b=-abs(b); 
radius=mean(sqrt((r-a).^2+(img-b).^2)); 
  
% Calculation of ro,ri,alf 
  
ro=a+(radius^2-b^2)^0.5; 
ri=a-(radius^2-b^2)^0.5; 
alf=1-(2/pi)*asin((ro-ri)/(2*radius)); 
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% Calculation of fc 
u=((r.^2-2*ri.*r+img.^2)+(ri^2)).^0.5; 
v=((r.^2-2*ro.*r+img.^2)+(ro^2)).^0.5; 
ww=log10(abs(u./v)); 
p=log10(2*pi*f); 
h=polyfit(p,ww,1); 
fc=((1/(2*pi))*10^(-h(2)/h(1))); 
  
  
    roo(hh,1)=ro; 
    rii(hh,1)=ri; 
    fcc(hh,1)=fc; 
    alff(hh,1)=alf; 
  
    cole=[roo rii fcc alff]; 
     
% Calculation of the error quadratic media 
  
ye=(-abs(b)+(radius^2.-(r-a).^2).^0.5); 
er=(abs(ye)-abs(img))./radius; 
ecm=(((sum(er.^2))^0.5)/n)*100; 
er2=(abs(ye)-abs(img))./abs(img); 
ecm2=(((sum(er2.^2))^0.5)/n)*100; 
ecm3=(sum(abs(er)))*100/n; 
  
if dib==1, 
     
    axis(axis);  
    dd=ro/ri; 
    dd=dd/150; 
    xx=[ri:dd:ro]; 
    c=1-(sin((pi/2)*(1-alf)))^2; 
    a=(ro+ri)/2; 
    b=((ro-ri)/2)*(c/(1-c))^0.5; 
    radius=(((ro-a)^2)+b^2)^0.5; 
    yy=(-abs(b)+(radius^2.-(xx-a).^2).^0.5); 
    figure(1) 
    plot(xx,abs(yy),'r'); 
    drawnow; 
    axis image 
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    hold on; 
     
end; 
end; 
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  نسجة الذم باستخذام القياسات الأومية الحيوية  أوصف
 
  إناس سعذي عبذ السلام قباجة: إعذاد
 
  عمر السرخي. د: اشراف
 
 
  ملخصال
 
 
انقٛاساخ الأٔيٛح انحٕٛٚح نٛسد يٍ انحقٕل انثحصٛح انعذٚذِ، إر إٌ انعًم فٙ ْزا انُٕع يٍ انثحٕز تذأ فٙ َٓاٚح انعاو 
  نكٍ يُز انقشٌ انًاضٙ اْرى انعذٚذ يٍ انثاحصٍٛ ٔيٍ يخرهف انًعالاخ فٙ ْزا انُٕع يٍ انثحٕز حٛس أٌ 0891
انعهًاء يٍ يخرهف انخهفٛاخ انثٕٛنٕظّٛ ٔانظُاعٛح ٔانطثٛح قذ قذيٕا انكصٛش يٍ انثحس ٔانرطٕٚش حٛس قايٕا تانعًع يا 
 .تٍٛ انركُٕنٕظٛا انحذٚصح ٔالانكرشَٔٛاخ ٔانثحٕز انطثٛح ٔانقٛاساخ الأٔيٛح انحٕٛٚح
 
ْزِ انرقُٛح نٓا انكصٛش يٍ انًضاٚا ٔالإٚعاتٛاخ يقاسَّ يع غٛشْا يٍ انرقُٛاخ حٛس أَٓا ذًراص تانركهفح انًُخفضّ نهقٛاساخ 
ٔ الأظٓضج، ٔسٕٓنح الاسرخذاو، ٔانقذسج عهٗ انرطثٛق غٛش انعشاحٙ، ٔذسًح تانًشاقثح انًثاششج، تالاضافح انٗ قهح 
 .انًخاطش انًشذثطح تٓزا انُٕع يٍ انقٛاساخ
 
تًُٛا ذعرثش انًقأيح يٍ انخظائض انًًّٓ لأ٘ يادِ فإٌ انقٛاساخ الأٔيٛح انحّٕٛٚ ذسرطٛع إعطاء يعهٕياخ قًٛح عٍ 
فٙ تعض الأحٛاٌ ذعرثش . انُسٛط ذحد انقٛاط، ٔتانرانٙ فإَّ تالإيكاٌ ذشخٛض انُسٛط أٔ يشاقثح انحذٔز انفسٕٛنٕظٛح
ٔٚرى عًم انقٛاساخ الأٔيٛح انحٕٛٚح تاسرخذاو  .انقٛاساخ الأٔيٛح انحٕٛٚح تذٚلا ًيًٓا ًنهقٛاساخ انرٙ لا ذحراض انٗ ظشاحح
يظذس ذٛاس خاسظٙ شى ٚرى اسرخذاو ْزِ انقٛاساخ نرحذٚذ طفاخ الأَسعح ذحد انقٛاط أٔ انحظٕل عهٗ يعهٕياخ أخشٖ 
 .تاسرخذاو انقٛاساخ الأٔيٛح
 
ٚشرًم انعًم فٙ ْزِ انشسانح عهٗ يشحهرٍٛ ذثعا ًنهعًم تاسرخذاو طشٚقح يحاكاج الأَسعح انثٕٛنٕظٛح أٔ انعًم عهٗ 
الأَسعح انثٕٛنٕظٛح انثششّٚ ٔذحذٚذا ًالأَسعح انذيٕٚح، ٔتانرانٙ ًٚكٍ ذقسٛى انعًم تحٛس ٚشرًم عهٗ انًخرثش انعاف 
انز٘ يُّ َحظم عهٗ انقٛاساخ الأٔنٗ ٔانًخرثش انشطة ٔانز٘ فّٛ ٚرى ذعًٛع انقٛاساخ انرعشٚثٛح ٔانقٛاساخ انثحصٛح 
 .عهٗ انرٕانٙ 
 
يٍ انًشحهرٍٛ انًزكٕسذٍٛ أعلاِ ٚرى انحظٕل عهٗ انقٛاساخ الأيٛح شى ٚرى ذشظًح ْزِ انقٛى ٔانقٛاساخ يٍ أظم 
انحظٕل عهٗ انًعهٕياخ انقًّٛ عٍ انُسٛط ذحد انقٛاط أٔ نٕطف الأَسعح انثٕٛنٕظٛح َٔحٍ َرحذز ُْا عٍ أَسعح 
انذو ذحذٚذا كًا ركشَا ساتقا، ٔتانرانٙ ٚرى ذشظًح ْزِ انًعهٕياخ إنٗ يعهٕياخ عٍ قًٛح َسثح خلاٚا انذو انحًشاء فٙ 
 .يحرٕٖ انذو، ٔانًحرٕٖ انًائٙ داخم خلاٚا انذو ٔخاسظّ
 
.  عُٛح دو طاصظح33ذى تُاء تشَايط خاص تاسرخذاو تشَايط انلاب فٕٛ لأخز قٛاساخ أٔيٛح تشكم يرٕاطم، ٔذى اسرخذاو 
ذى  نكم عُٛح دو ذى أخز انقٛاساخ الأٔيٛح عهٗ سرح ذشدداخ ْٔٙ انرشدداخ الأكصش اسرخذايا ًفٙ يصم ْزِ انقٛاساخ حٛس
يٍ أظم ذحهٛم انًعهٕياخ ٔانثٛاَاخ ذى تُاء كٕد خاص تاسرخذاو تشَايط انًاذلاب، . ركشْا فٙ انًٕاقع راخ انعلاقح
تحٛس ذى يٍ خلانّ احرٕاء انقٛاساخ انرٙ ذشًم انًقأيح ٔانضأٚح ٔكٛف أٌ انًقاسيح ُْا ْٙ اقرشاٌ نّ علاقح تانرشدد 
 كٕل ٔانرٙ ذشًم انًقأيح –ٔيٍ شى ذى اسرخشاض انًرغٛشاخ انرٙ ٚرضًُٓا ًَٕرض كٕل .  كٕل–ٚاسرخذاو ًَٕرض كٕل 
 .الإترذائٛح ٔانًقأيح انُٓائٛح ٔانرشدد انًًٛض ٔذشدد الاسرشخاء أنفا
 
 كٕل، شى ذى اسرخذاو –تعذ رنك ذى اسرقشاء قٛى كم يٍ انًقأيح الاترذائٛح ٔانًقأيح انُٓائٛح تالاعرًاد عهٗ ًَٕرض كٕل 
انًقذساخ الأكصش شٕٛعا ًيٍ أظم ذحذٚذ انحعى خاسض انخهٕ٘ ٔانحعى تٍٛ انخلاٚا ٔفٙ انُٓاٚح ٚرى ذحذٚذ قٛى َسثح خلاٚا 
 .انذو انحًشاء يٍ حعى انذو كهّ تالاعرًاد عهٗ قٛى انحعٕو انرٙ ٚرى انحظٕل عهٛٓا
 
 ذى فٙ ْزا انعًم انًقاسَح تٍٛ انعذٚذ يٍ انًقذساخ انًٕظٕدج ٔانرٙ ذشًم يقذس انعٛم الأٔل نششكح شرشٌٔ ٔيقذس 
نكم عُٛح دو يٍ . انعٛم انصاَٙ تالإضافح إنٗ يقذس ظذٚذ ذى اسرحذاشّ يٍ قثم انذكرٕس عًش انسشخٙ يششف انشسانح
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 انساتقح انزكش ذى ذقٛٛى دقح ْزِ انًقذساخ فٙ ذقٛٛى انًحرٕٖ انًائٙ ٔذحذٚذ َسثح خلاٚا انذو انحًشاء يٍ 33انعُٛاخ ال 
حعى انذو ٔيقاسَح ْزِ انُسثح يع انُسثح الأطهٛح انرٙ ذى قٛاسٓا قثم ٔتعذ انعًم عهٗ عُٛاخ انذو تاسرخذاو ظٓاص ذحهٛم 
 .انذو فٙ كم يٍ يسرشفٗ انخهٛم انحكٕيٙ ٔيخرثشاخ كهٛح انطة فٙ ظايعح انقذط
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
